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Abstract
STATISTICAL METHODS FOR NORMALIZATION AND ANALYSIS OF
HIGH-THROUGHPUT GENOMIC DATA
By Tobias Guennel, Dipl.-Math. techn.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2012
Major Director: Mark Reimers, Ph.D., Assistant Professor, Department of Biostatistics
High-throughput genomic datasets obtained from microarray or sequencing studies have
revolutionized the field of molecular biology over the last decade. The complexity of these
new technologies also poses new challenges to statisticians to separate biological relevant
information from technical noise. Two methods are introduced that address important
issues with normalization of array comparative genomic hybridization (aCGH) microar-
rays and the analysis of RNA sequencing (RNA-Seq) studies. Many studies investigating
copy number aberrations at the DNA level for cancer and genetic studies use compar-
ative genomic hybridization (CGH) on oligo arrays. However, aCGH data often suffer
from low signal to noise ratios resulting in poor resolution of fine features. Bilke et al.
[11] showed that the commonly used running average noise reduction strategy performs
poorly when errors are dominated by systematic components. A method called pcaCGH
is proposed that significantly reduces noise using a non-parametric regression on technical
covariates of probes to estimate systematic bias. Then a robust principal components
analysis (PCA) estimates any remaining systematic bias not explained by technical co-
variates used in the preceding regression. The proposed algorithm is demonstrated on
two CGH datasets measuring the NCI-60 cell lines utilizing NimbleGen and Agilent mi-
croarrays. The method achieves a nominal error variance reduction of 60%-65% as well
as an 2-fold increase in signal to noise ratio on average, resulting in more detailed copy
number estimates. Furthermore, correlations of signal intensity ratios of NimbleGen and
Agilent arrays are increased by 40% on average, indicating a significant improvement in
agreement between the technologies.
A second algorithm called gamSeq is introduced to test for differential gene expression in
RNA sequencing studies. Limitations of existing methods are outlined and the proposed
algorithm is compared to these existing algorithms. Simulation studies and real data are
used to show that gamSeq improves upon existing methods with regards to type I error
control while maintaining similar or better power for a range of sample sizes for RNA-Seq
studies. Furthermore, the proposed method is applied to detect differential 3’ UTR usage.
Chapter 1
Introduction
A new era in science is usually heralded by the adoption of a new technology that in-
creases throughput by an order of magnitude and exponentially reduces cost compared
with existing approaches. In the field of molecular biology, scientists have been witnesses
and drivers of two intertwined eras over the last two decades: the eras of microarrays and
next-generation sequencing (NGS). Microarrays evolved from Southern Blotting, where
fragmented DNA is attach to a substrate and then probed with a known gene or fragment
and were first reported in the late 1980’s and early 1990’s [4, 5, 53]. It took microarray
technology until the mid to late 1990’s, when miniaturized microarrays were first used for
gene expression profiling and a complete eukaryotic genome could be fit onto a microar-
ray [43, 90], to develop the throughput and cost efficiency to revolutionize how scientists
were investigating molecular processes. Since then the uses for microarrays have increased
exponentially to provide new insights into DNA methylation, copy number variation via
DNA genotyping and array comparative genomic hybridization (aCGH), and protein bind-
ing site usage through chromatin immunoprecipitation assays to name a few [28, 30, 91].
In a typical microarray experiment, a mRNA or DNA sample from a given cell type or
1
Figure 1.1. Worflow of a typical aCGH experiment [101].
tissue is used to generate a labeled sample, sometimes termed the ’target’, which is hy-
bridized in parallel to a large number of DNA sequences, immobilized on a solid surface in
an ordered array. The density of DNA sequences that can be attached to the microarray
surface allows the detection and quantification of up to several millions of targets simul-
taneously.
One application for microarray technology is the detection of copy number variations in
DNA samples through aCGH. Figure 1.1 illustrates the workflow of an aCGH microarray
experiment. First, DNA is extracted from a test and a normal control (reference) sample
and both are labeled with a fluorescent dye of different colors after DNA fragmentation.
The two genomic DNA fragment samples are then washed over a microarray and since
the DNA has been denatured, its fragments are single stranded and attempt to hybridize
with the arrayed single-strand probes. Next, digital imaging systems are used to capture
and quantify the relative fluorescence intensities of the labeled DNA probes that have
2
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
ll
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
lll
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
−
2
−
1
0
1
2
3
Cell Line  SK−MEL−5 ; Chromosome  chr17
Genomic Position
lo
g2
(T
/R
)
48539 18512631 37620649 58855829 78623171
Figure 1.2. Example of intensity ratios for aCGH experiment.
hybridized to each target. The fluorescence ratio of the test and reference hybridization
signals is determined at different positions along the genome and provides information
on the relative copy number of sequences in the test genome as compared to the normal
genome. Intensity ratios are log2 transformed and an example how these ratios are repre-
sented is shown in Figure 1.2. Here, log ratios of zero indicate no copy number variation
while positive and negative ratios indicate copy number gains or losses, respectively. De-
tecting copy number variations ultimately transforms into a change point problem where
scientists want to pin-point genomic regions of elevated or decreased copy number ratios
as exactly as possible. It is apparent in Figure 1.2 that these ratios are quite noisy and
normalization methods that improve signal to noise ratios allow more accurate detection
of change points are needed. Chapter 2 introduces a novel algorithm to normalize aCGH
data and compares it to existing methods.
After microarrays had become the most common technology for investigating molecu-
3
lar processes on a genome-wide scale, scientists were looking for a technology that would
overcome some of the pitfalls of microarray technology including for example a limited
dynamic range and reliance on manufactures to provide accurate assays for their bio-
logical question of interest. This new technology took center stage in 2008 when the
first complete human diploid genome was sequenced using Roche’s 454 sequencing plat-
form [108] to perform massively parallel DNA sequencing. Since then, high-throughput
or next-generation sequencing has revolutionized the field of molecular biology in recent
years replacing microarrays as the method of choice for many genome-wide studies of
transcription levels (RNA-Seq), DNA-protein interactions (ChIP-Seq), chromatin struc-
ture and DNA methylation (Methyl-Seq) [22, 29, 51, 58, 60]. The basic principle behind
DNA sequencing is that DNA fragments are not hybridized to probes attached to a glass
surface but rather sequenced directly. Sanger sequencing [89] had long been the choice for
sequencing small numbers of DNA fragments, but the need for low-cost sequencing spurred
the development of the above mentioned technologies that can sequence millions of DNA
fragments in parallel. Numerous sequencing platforms lead by Illumina’s HighSeq and
GenomeAnalyzer systems [57] and Applied Biosystem’s SOLiD system [54] have emerged
and provide scientists with a myriad of possibilities to quantify molecular processes on a
genome-wide scale with high resolution. For schematics how these two platforms sequence
DNA fragments, please refer to Figures B.1 and B.2 in Appendix B. A detailed review of
these and other NGS technologies can be found in [54]. The increase in throughput and
cost reduction that could be achieved through massive parallel sequencing was enormous.
While scientists could sequence six Megabases per day at $500 per Megabase sequenced
with Sanger sequencing, Roche’s 454 platform has a throughput of 750 Megabases a day at
$10 per Megabase while Illumina’s HighSeq platform and ABI’s SOLiD platform achieve
up to 35 Gigabases per day at $0.10 per Megabase [25]. These cost savings have led to an
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exponential increase in experiments utilizing NGS and new methods to normalize and an-
alyze these datasets are needed. Although early studies claimed that NGS is less prone to
technical artifacts than microarrays [51, 106], it has become clear that this technology has
its own pitfalls [15, 22, 27, 57, 85, 87]. While these studies show that quality assessment
and normalization are important for NGS data, the second part of this thesis focuses on
the subsequent step, i.e. the analysis of quality assured data. More specifically, meth-
ods for analyzing gene expression data obtained through RNA sequencing (RNA-Seq)
are considered. Figure 1.3 shows a schematic of a typical RNA-Seq experiment. First,
mRNA from a tissue of interest is extracted, fragmented and reverse transcribed. These
cDNA fragments are then pre-processed and sequenced according to protocols supplied
by the manufacturer of the sequencing platform. The short sequence reads obtained from
the sequencing run are then aligned to a reference genome. Using this reference genome,
the researcher can then define a gene model of choice by defining genomic regions that
represent a gene. Gene expression levels are determined by counting how many reads fall
into these pre-defined regions. Once count data for each gene and sample are obtained,
the data is ready for analysis.
In Chapter 3, existing methods to analyze gene expression data obtained through
RNA-Seq are assessed. A new algorithm to analyze RNA-Seq data is proposed and com-
pared to existing methods in Chapter 4. Furthermore, the flexibility of the proposed is
illustrated in Chapter 5.
5
Figure 1.3. Workflow of a typical RNA-Seq experiment [106].
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Chapter 2
Normalization of aCGH Microarrays
2.1 Introduction
Copy number variation (CNV) of DNA sequences has long been suspected to be a form
of normal genetic variation and to play an important role in many genetic disorders.
However, only recently has its importance in human diversity been demonstrated by
Sebat et al. [92] and Iafrate et al. [33]. In a subsequent study, Redon et al. [79] found
quantitative evidence showing that CNV regions cover at least 12% of the human genome
and more nucleotide content per genome than single nucleotide polymorphisms (SNPs).
DNA copy number changes are also consistently observed in cancer cells where different
types of cancers show different copy number structures [35, 55]. More interestingly, Weiss
et al. [107] and Van Wieringen et al. [103] observed correlations between CNV and
clinical outcomes such as patient survival and responsiveness to certain treatments. In
this light, obtaining accurate and reliable estimates of chromosomal copy numbers has
become increasingly important.
Chromosomal comparative genomic hybridization (cCGH) was introduced by Kallion-
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iemi et al. [36] as method to investigate DNA copy number alterations on a genome-wide
scale. cCGH is capable of detecting loss, gain, and amplification of genomic regions with
different sensitivities for different copy number alterations. Copy number amplifications
can be detected in regions of less than 1 Mb, while a single copy loss can be difficult
to detect in regions of less than 5 Mb in length. With the emergence of microarrays,
array comparative genomic hybridization (aCGH) offered improved resolution, a higher
dynamic range, and improved throughput, along with a convenient way to access the loca-
tion of copy number alterations on the genomic map [70]. In a typical aCGH experiment,
genomic DNA from test and reference cells is isolated, labeled with two different fluores-
cent dyes and hybridized on an oligo microarray. After removing excess dye particles, a
high resolution camera takes pictures of each channel, which are subsequently scanned
and transformed into test and reference channel intensities. Typically, the ratio of test
to reference channel intensity (T/R) on a log2 scale is used to investigate copy number
variations. Since the reference genome is assumed to have very few copy number varia-
tions, any significant departures from zero in the log2(T/R) ratios indicate copy number
aberrations in the test sample.
Many early studies using aCGH have focused on amplifications where 10 or more extra
DNA copies are present. Lately detecting heterozygous deletions and subtle gains of one
or more extra DNA copies or detecting short to moderate length copy number aberrations
has become of increasing interest [10, 111]. However, low level copy number changes are
difficult to detect due to the low signal to noise ratios of current aCGH technologies. The
most commonly used approaches to increase signal to noise ratios during the analysis of
CNV are variants of neighbor dependent methods that average signal intensities of neigh-
boring probes [11, 47]. For example, the running average (RA) method [32, 71] calculates
an average signal intensity from all neighboring probes contained in a windows of size W .
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Then, a sliding window is used to define regions of size W across the genome that are
investigated for copy number changes. The success of those methods in detecting small
segments of CNV depends on the length of the window selected, which in turn depends
on the signal to noise ratio in the data after pre-processing. Smaller signal to noise ratios
allow for smaller segments to be averaged, which consequently results in higher resolution.
Conducting a microarray experiment is a multi-step process during which technical
variation can be introduced by several sources. Technical variation is considered to be
any variation induced by differences in sample handling or the hybridization process. A
technical covariate is a variable that indexes differential effects of these differences in han-
dling on log-ratio intensities. If the magnitude of technical variation is comparable in size
to the magnitude of biological variation, the experiment is unlikely to yield statistically
significant biological differences. The first stage of the proposed algorithm aims to reduce
variation which can be indexed or predicted by known technical covariates. Normalization
methods adjusting for technical covariates have been developed for ChIP-chip arrays [48]
as well as Affymetrix gene expression [109]. Chen et al. [17] pointed out that normaliza-
tion methods for aCGH data are rare and that researchers often apply methods developed
for gene expression data in a slightly modified form to aCGH data. These authors demon-
strate using simulated aCGH data that this approach is problematic due to the different
nature of aCGH data, where the most important differences lie in smaller dynamic ranges
and dependencies among probes based on genomic position. Neuvial et al. [63] uncovers
continuous spatial biases as well as local spatial biases in BAC aCGH data, and stresses
the importance of correcting for spatial artifacts for meaningful biological inferences.
Several methods have been proposed to increase signal to noise ratios during pre-
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processing of aCGH data. Median and quantile normalization [14] usually used for nor-
malizing gene expression microarray data have also been used with aCGH data. Median
normalization centers the distribution of log intensity ratios at its median and thus does
not affect signal to noise ratios as it only shifts the distribution. Quantile normalization
calculates a reference distribution of log2 intensity ratios using all arrays in the data set
and then replaces intensity ratios for individual arrays with the corresponding quantile
of the reference distribution. The reference distribution is usually obtained by averaging
corresponding quantiles from individual arrays across all arrays. Lepretre et al. [46] have
proposed their waves aCGH correction algorithm (WACA) that uses a locally weighted
scatterplot smoothing (LOESS) fit [19] based on GC content and fragment size correction
to improve accuracy. Staaf et al. [99] propose an algorithm that performs population-
based intensity-based LOESS (popLowess) smoothing. The algorithm first stratifies data
into populations of copy numbers and then performs LOESS normalization based on M-A
plots [96].
The proposed algorithm consists of two parts. First, a non-parametric locally weighted
linear regression (LOESS) is used to estimate systematic bias due to variables that induce
technical variation. Second, a principal component analysis (PCA) is employed to account
for any unknown technical covariates that could further cloud the biological information
contained in the data. A detailed description of the algorithm is provided in the following
section.
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2.2 Materials and Methods
2.2.1 Datasets
In the late 1980’s, the National Cancer Institute (NCI) prepared a drug testing pipeline
whose first screening stage measured the effect of putative anti-cancer agents on various
cancer cell lines. To this end they gathered 60 cell lines, several of which (such as MCF-7)
had been previously widely used in cancer research. These 60 cell lines came from nine
distinct tissues of origin (although some were misclassified initially): breast, brain, colon,
lung, kidney, ovary, prostate, lymphocytes and melanocytes.
Samples of those 60 cell lines were hybridized to Agilent Human Genome CGH Mi-
croarray 44K [1] and NimbleGen HG17 CGH 385K WG Tiling [64] arrays. A summary
of each dataset is shown in Table 2.1. Thus, three datasets were available for analy-
sis: two consisting of signal intensities obtained from NimbleGen [81] and Agilent arrays
with standard dye assignments to test and control samples and one consisting of signal
intensities obtained from Agilent arrays where the dye assignments to test and control
samples were reversed. Note that the Agilent datasets contained four replicates for cell
line A549-ATCC and also that cell line NCI-H226 was excluded from analysis due to low
data quality. Furthermore, the experiment using NimbleGen arrays contained ten repli-
cates for cell line A549-ATCC, including four dye swaps, and four replicates for cell lines
SF-268 and OVCAR-8. The intensities used for analysis were the perfect match (PM)
intensities provided by Nimblescan v2.3.4 for the NimbleGen arrays and the processed in-
tensities provided by Agilent’s Feature Extraction Software v8.1.18. In a later stage each
probe’s neighbors on the genome are identified by locating each probe by BLAT search.
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The probes on the Agilent and NimbleGen aCGH platforms used here were based on the
UCSC version HG19 [38, 42]. All probes on either platform that did not align uniquely
to the most current human assembly built were dropped from the analysis reducing the
effective number of probes per array (see Table 2.1). The data sets are publicly available
on the CellMiner webpage [93] at http://discover.nci.nih.gov/cellminer.
Table 2.1. Summary of Agilent and NimbleGen Datasets
Agilent NimbleGen
Array Description
Human Genome HG17 CGH 385K
CGH Microarray 44K 2005-03-16 HG17 WG CGH
Number of Probes per Array 44000 385000
Effective Number of Probes (I) 42853 378779
Length of Probe Sequence 60 mer 45-85 mer
Median Probe Spacing 43000 bp 5000 bp
Number of Arrays (K) 124 72
Number of Dye Swaps 62 4
2.2.2 Algorithm
The principle idea behind the proposed algorithm is the following partition of a data
matrix M of intensity ratios:
M = M biological +M systematic +M random. (2.1)
Here, M biological represents signal due to biological differences of interest, M systematic
represents systematic noise due to technical covariates, and M random represents random
noise. The goal is to normalize the raw data matrix M by estimating M systematic and
removing the corresponding residuals:
M ∗ = M − M̂ systematic. (2.2)
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The following sections introduce a two step algorithm that aims to obtain good estimates
of M systematic to remove as much systematic noise as possible.
Technical Covariate Normalization
A non-parametric regression approach using LOESS was employed to account for sus-
pected technical variables inducing non-biological variation. Locally weighted least squares
regression (LOESS regression) is a technique to fit a smoothing surface to the data us-
ing second order polynomials. After carefully investigating the dependence of log-ratios
on a variety of potentially informative technical covariates, the following probe specific
technical covariates for aCGH experiments were identified:
1. horizontal and vertical coordinates indexed by probe position X and Y on the array,
2. average reference channel intensity G across all arrays,
3. difference of reference channel intensity Gk to average reference channel intensity G
across all arrays, and
4. probe GC content GC.
For the purposes of this algorithm, the dependent variable is Mki = log2(Tki/Rki), the
ratio of the raw probe intensities of probe i, i = 1, . . . , I, for array k = 1, . . . , K, on a log2
scale. Then the LOESS model is specified by
Mki = f(Xi, Yi, GCi, Gki −Gi, Gi) +  (2.3)
where f represents a nonlinear function, in this case a local regression surface, and 
represents biological signal plus error not predictable from the technical covariates used.
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The normalized log2 intensity ratios are obtained by
MLOESSki = Mki − M̂ki, (2.4)
where M̂ki are the log2 intensity ratios as predicted from the technical covariates alone by
the LOESS model in Equation 2.3.
The following paragraphs describe the empirical evidence that led to the choice of
technical covariates. By design, microarray probes are randomly distributed across an
array to avoid spatial biases, i.e. probes that represent adjacent regions on the genome
are not located physically adjacent on an array. Therefore, in the absence of spatial ar-
tifacts, one would expect a random pattern of high ratios, low ratios, and ratios of one,
across an array. Furthermore the distribution of reference channel intensities should be
fairly homogeneous across the whole array as reference DNA was extracted from healthy
cells, i.e. cells for which the vast majority of DNA regions should have a copy number
of two. It is known that even healthy cells contain some DNA regions with deletions or
amplification, but probes measuring copy numbers for those sparse regions should again
be randomly distributed across the array. Reimers and Weinstein [80] introduced quality
assessment plots for microarray data to visualize spatial artifacts of regional biases. Fig-
ures 2.1 and 2.2.a) show plots of log2 reference channel intensities and log2 intensity ratios,
respectively, by physical probe position on two specific NimbleGen arrays. Two types of
non-random patterns can clearly be identified, continuous spatial gradients and distinct
local spatial artifacts. Considering log2 intensity ratios, continuous spatial gradients were
detected on numerous NimbleGen as well as Agilent arrays and a significant number of
NimbleGen arrays and a few Agilent arrays showed local spatial artifacts. Those patterns
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Figure 2.1. Spatial Artifacts in Reference Channel for NimbleGen Arrays: Plots show
deviations from average reference channel intensities for two NimbleGen arrays
seem to be even more pronounced for reference channel intensities on NimbleGen arrays.
To account for spatial artifacts in the reference channel of aCGH data, the reference
channel intensity for each array, as well as the difference of reference channel intensity to
average reference channel intensity across all arrays were used in the LOESS regression.
Let i, i = 1, . . . , I, denote the ith probe on a aCGH array. The average reference channel
intensity Gi for probe i is calculated as a 10% trimmed mean of Gki for all k = 1, . . . , K
where K is the number of arrays in an aCGH dataset and
Gi =
1
0.8K
[(L− 0.2 ∗K)(G(L)i +G(K−L+1)i) +
K−L∑
j=L+1
G(j)i], (2.5)
where L = b0.2Kc + 1 and G(j)i denotes the jth ordered reference channel intensity.
Equation 2.5 can similarly be used to calculate trimmed means of continuous data vectors
x and this calculation will be abbreviated by Mean10%(x) in the following.
Agilent arrays also show non-random patterns (plots not shown), but the frequency
and magnitude of those patterns were much smaller compared to NimbleGen arrays. Fur-
15
Figure 2.2. Impact of Normalization on Spatial Artifacts: Plots show deviations from
average log2 intensity ratios a) before and b) after normalization
16
thermore, Agilent’s Feature Extraction Software v8.1.18 pre-processing step of the raw
intensities produces similar effects as stage 1 of the proposed algorithm and therefore only
stage 2 was applied to the Agilent intensities. It should be noted that newer versions
of NimbleScan (v2.5 and higher) also include LOESS based spatial correction to adjust
signal intensities based on physical feature position. The algorithm should be adjusted to
the corresponding software version to avoid overcorrection of real biological signal.
Wu et al. [109] have shown that melting temperature can influence probe intensi-
ties. The melting temperature Tm of a DNA strand is defined as the temperature where
one-half of its nucleotides are paired with their complement while one-half are unpaired.
Ideally, each probe on the array should have the same melting temperature. However,
since each probe must uniquely identify one specific region of the genome, heterogeneous
melting temperatures across an array are common and need to be accounted for. A
probe’s GC content is a good proxy of its melting temperature. Furthermore, several
studies [52, 61, 98] have identified probe GC content as an important source of technical
variation.
The LOESS curve is fit using the loess function implemented in the R programming
environment [77]. Since the loess function can only fit four predictors at a time, two
LOESS surfaces were fit and the corresponding residuals were subtracted sequentially.
The first LOESS surface fits predictors related to spatial properties, i.e. horizontal and
vertical coordinates indexed by probe position X and Y on the array, average reference
channel intensity G across all arrays and difference of reference channel intensity Gk to
average reference channel intensity G across all arrays. The second LOESS surface fits
GC content by itself as this is a sequence specific predictor. Due to the evident fine-scale
17
structure in Figures 1 and 2, a span of 1% is used, i.e. 1% of the data is used to fit each
local regression, for the first LOESS fit. On the other hand, the dependence on probe
GC content is smoother, and therefore a span of 30% in the second LOESS fit was used.
In principle the size of the LOESS span was chosen to use up approximately 1% of the
total available degrees of freedom. It was found however that using a span smaller than
1% increases the computational burden substantially while only marginal improvement in
normalization performance could be achieved.
Robust Principal Component Analysis of Residuals
The novel part proposed here is the combination of technical covariate normalization with
principal component analysis (PCA) to uncover any remaining systematic patterns due to
unaccounted technical variation after accounting for specific variables that are expected to
index unwanted technical variation in stage 1. The goal of PCA is to find a few principal
components that explain the majority of variance inherent in the data, i.e. to perform a
dimensionality reduction of the data. Specifically, a data matrix X ∈ RI×K is modeled
as
X = DτY τ +E. (2.6)
Here, Dτ ∈ RI×p denotes the transpose of the reduced rotation matrix containing only
the first p principal directions, Y τ ∈ Rp×K contains coordinates of each data point in the
new coordinate system, i.e. Y τ constitutes the transpose of the rotated data matrix, and
E ∈ RI×K are the corresponding residuals [45].
PCA is a special case of projection pursuit which maximizes the magnitude of a pro-
jection index PI after projection multidimensional data into a one-dimensional subspace.
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Formally, the jth principal direction aj is defined by
aj = arg max
‖a‖=1,a⊥a1,...,a⊥aj−1
PI(atx1, . . . ,a
txn) (2.7)
where x1, . . . ,xn are I-dimensional data points. Using the sample variance as projection
index corresponds to PCA, i.e. finding the eigenvalues of the sample covariance matrix and
the corresponding eigenvectors are the principal directions. PCA is not a robust method
as outliers can significantly influence the obtained principal components and directions,
Croux et al. [21] suggested using the median absolute deviation (MAD) as projection
index to deal with the high incidence of outliers in microarray experiments [44, 59]. An
efficient version of this algorithm is implemented in the R function PCAGrid within the
package pcaPP [23].
The proposed approach is based on the inherent characteristic of aCGH data, that
signal intensities of neighboring probes are highly correlated. Specifically, the approach
takes advantage of the common situation that probes that are in close proximity measure
the same copy number. The difference MLOESSki −M
′
ki between ratios of a specific probe
and its neighboring probes is partitioned into a systematic part and a random part, i.e.
X = MLOESS −MLOESS in Equation 2.6 where MLOESS = {MLOESSki }i=1,...,I;k=1,...,K
and M
LOESS
= {MLOESSki }i=1,...,I;k=1,...,K . Here, MLOESSki denotes the 10% trimmed
mean of probes within a window of window size W around probe i. The difference
MLOESS −MLOESS ∈ RI×K can then be viewed as a matrix of bias estimates, one for
each probe of each array. The accuracy of the bias estimates dependents on the window
size W as well as the validity of the assumption that neighboring probes measure the same
copy number. Therefore an iterative algorithm is used to find a window large enough to
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provide an accurate bias estimate while testing the validity of the above mentioned as-
sumption. The window size W is calculated by iteratively including up- and downstream
probes xi−h and xi+j, h = 1, . . . , H; j = 1, . . . , J , closest to probe i up to a maximum
window size of Wmax = 30 for Agilent arrays and Wmax = 60 for NimbleGen arrays, i.e.
Hmax = Jmax = 15 and Hmax = Jmax = 30, respectively. The maximum window sizes are
chosen based on the probe density of the respective array to ensure that probes in relative
proximity to the probe for which the bias ought to be estimated are chosen. At each step
of the iterative inclusion process, an ad-hoc test is used to compare whether the inclusion
of additional probes could possibly lead to the inclusion of a true copy number change due
to a biological process. If an actual change in copy number is suspected, the current probe
and all probes farther away from probe i are not included in the corresponding window.
This comparison is performed for the up- and downstream regions independently and
therefore the resulting window may not be symmetric. The ad-hoc test used to test for a
true change in copy number after each iteration is based on a Smith-Waterman algorithm
described in [74] and implemented in the R package cgh by Price et al. [75].
The normalized probe log2 intensity ratios M
PCA
ki are then given by subtracting the
systematic bias predicted by the principal components from the original log2 ratio inten-
sities:
MPCA = MLOESS −DτY τ = MLOESS +E, (2.8)
where MPCA = {MPCAki }i=1,...,I;k=1,...,K . E is obtained by performing a robust PCA as
described above on MLOESS −MLOESS and retaining the first p principal components,
i.e.
E = MLOESS −MLOESS −DτY τ . (2.9)
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The number of principal components kept is determined by scree plots. Scree plots show
the size of the principal components in decreasing order. If there is a strong systematic
component, the scree plot will level off at some point and all principal components up
to this point are retained. While it is not exact, the scree plot method is a reasonable
approach. A great difference in performance was not observed when one or two additional
PCs judged to be optimal from the scree plot were used. The scree plots for both Agilent
and NimbleGen data are shown in Figure 2.3. The plots level off after the third and
fourth principal component and thus three and four principal components are retained
for Agilent and NimbleGen data, respectively. For further details on PCA, please refer to
Johnson & Wichern [34] and Croux et al. [21]. The procedure outlined above assumes that
probes that are in close proximity measure the same copy number in the majority of cases,
and therefore that MLOESS −MLOESS measures variability due to technical covariates
and not biological signal. The iterative algorithm used to estimate the error structure
was designed to automatically assess this assumption during the estimation process and
ensure the validity of the PCA performed.
2.2.3 Performance Measures
The following qualitative and quantitative measures to assess the performance of the
proposed normalization method were used:
• quality assessment plots visualizing spatial artifacts before and after normalization,
• the Derivative Log2Ratio Spread (DLRS) investigating the variance reduction in
differences between adjacent probes,
• signal to noise ratios of technical replicates of cell lines A549-ATCC and SF-268,
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Figure 2.3. Principal Components for Agilent and NimbleGen Data: Scree plots
obtained by robust principal components analysis of residual differences between
neighboring probes
• signal to noise ratios of arrays and their corresponding dye swaps of the same cell
line in the Agilent dataset,
• concordance between NimbleGen and Agilent arrays, and
• median aberrant region lengths as a measure of resolution depth.
Several of these performance measures have also been used in a recent study comparing
several aCGH platforms [68].
Derivative Log2Ratio Spread
The Derivative Log2Ratio Spread (DLRS) was introduced by Kincaid et al. [39] and is
implemented in Agilent’s own DNAanalytics software as the metric of choice for noise
quantification. It calculates a robust variance estimate of the difference in log2 intensities
of neighboring (with respect to chromosomal location) probes. The principal assumption
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is that the majority of adjacent probes measure the same copy number. In fact, the DLRS
assumes that less the 50% of probes delimit breakpoints [46]. Let
Dmethodi,i+1;k = M
method
k(i+1) −Mmethodki ; i = 1, . . . , I − 1; k = 1, . . . , K, (2.10)
denote the difference in log2 intensity ratio of adjacent probes i and i + 1 on array k for
a specific normalization method (or the raw data). The DLRS for array k and a specific
method is given by
DLRSmethodk =
Q3(D
method
k )−Q1(Dmethodk )
1.349 ∗ √2 (2.11)
where Dmethodk = D
method
i,i+1;k i=1,...,I−1;k=1,...,K and Qn(D
method
k ) denotes the nth quartile of the
corresponding distribution of differences. The DLRS, presented as a robust method of
estimating noise from the sample array alone, can range from under 0.2 for an excellent
array to higher than 0.3 for poor experiments. One way to evaluate the mean efficiency
of an algorithm can then be written as
DLRSmethodeff =
1
K
K∑
k=1
DLRSrawk −DLRSmethodk
DLRSrawk
. (2.12)
Signal to Noise Ratios
Signal to noise ratios for technical replicates and dye swaps were estimated. For the
four replicates of the A549-ATCC sample, the mean variance within replicates estimated
using a robust estimator based on the median absolute deviation (MAD) was used as an
estimate of the dynamic range (signal) while noise was estimated by the median of the
variance across replicates calculated for all probes. Specifically, the signal to noise ratio
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was calculated using
SN =
1
K∗
∑K∗
k∗=1(1.4826 ∗MAD(Mmethodk∗ ))2
Median({V ar(Mmethodi )}i=1,...,I)
(2.13)
where K∗ is the number of replicates, Mmethodk∗ = {Mmethodik∗ }i=1,...,I ,
Mmethodi = {Mmethodik∗ }k∗=1,...,K∗ , and V ar(x) is the usual variance estimator.
Agreement between Technologies
To assess if there was an improvement in agreement between the two different aCGH plat-
forms, detection call intensities obtained from StepGram [47] with default settings were
used to compare technologies. Since the HG17 385K NimbleGen arrays have significantly
more probes than the CGH 44K WG Agilent array, the comparison was made between
each Agilent probe and the closest NimbleGen probe within a 15kb window. If no probe
was located within a 15kb window, the corresponding Agilent probe was omitted in this
analysis. The following metrics were used to assess improvement between technologies:
1. the proportion of variance (scaled by geometric mean of total variance in the two
data sets) explained in differences between matched Agilent and NimbleGen probes
with respect to the raw data, i.e.
V arexplained = 1−
V ar(A∗Norm−N∗Norm)√
V ar(ANorm)∗V ar(NNorm)
V ar(A∗raw−N∗raw)√
V ar(Araw)∗V ar(Nraw)
,
2. the correlation between signal intensities of the two platforms before and after nor-
malization, and
3. the proportion of corresponding probes with the same detection call, i.e. pairs of
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probes from different platforms that were both called a deletion, amplification, or
neither.
While reporting correlation is more common, the first measure of agreement, the propor-
tion of scaled variance explained, seems preferable since the correlation measure is often
influenced by the large dynamic range of the array measures while the this measure is
scaled by total variance.
Resolution after Segmentation
While improvements in the quantitative performance measures mentioned above are useful
to assess how well normalization methods reduce noise levels, researchers are ultimately
interested in called regions with copy number aberrations. Improvements in this out-
come are difficult to measure, absent an independent assessment of true copy number
aberrations. Nevertheless the following measures calculated using copy number ratio calls
obtained from StepGram are useful empirical measures that can be used to assess whether
reduced noise levels have an impact on the ability to detect regions with copy number
aberrations:
1. median aberrant region length (MARL),
2. proportion of probes called aberrant (PPCA), and
3. median MAD across all cell lines after segmentation (MMAS).
The first two measures assess the resolution after segmentation. Reduced noise levels can
have a significant impact on copy number ratio calling. Although the true aberration
lengths are not known, it would be expected that if the MARL is reduced in the presence
of a similar PPCA, the segmentation algorithm is able to better distinguish between
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regions of differing copy numbers. Furthermore, the MMAS is a useful measure of the
dynamic range of the data since segmentation algorithms smooth the data and remove
noise based on statistical algorithms and segmented data therefore represent biological
information for the most part. While normalization methods aim to reduce noise levels, the
biological information that is of interest should not be normalized out by any normalization
procedure. Thus, after segmentation, the MAD, which is expected to be driven mostly
by biological differences between disease samples and genomic references, should be of
similar magnitude before and after normalization. Any significant reduction in MMAS
indicates that the normalization procedure does not only remove noise due to technical
variation but also biological interesting information.
2.2.4 Implementation
The approach outlined above is implemented in the R package pcaCGH available at
www.people.vcu.edu/∼mreimers. Basic parallel computing capabilities were implemented
to ensure efficiency. Currently, the NimbleGen Human Genome HG17 CGH 385K (remapped
to HG19) and the Agilent CGH Microarray 44K 2005-03-16 HG17 WG CGH (remapped
to HG19) are supported. Output from Nimblescan v2.3.4 for the NimbleGen arrays and
the processed intensities provided by Agilent’s Feature Extraction Software v8.1.18 were
used in this study. Additional chip types as well as output from the Nimblegen’s Nim-
blescan and Agilent’s Feature Extraction Software can be added by request.
2.3 Results
The proposed method was applied to the three datasets introduced in the previous section
and evaluated each performance measure for the proposed method as well as the following
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existing methods:
1. median normalization, Bolstad et al. [14], R package limma version 3.4.5,
2. quantile normalization, Bolstad et al. [14], R package limma version 3.4.5,
3. popLowess, Staaf et al. [99], R package popLowess version 1.0.2, and
4. WACA, Lepretre et al. [46], R code provided by author.
Each method was applied as recommended by the authors. WACA was designed specif-
ically for Agilent aCGH microarrays and therefore was not used with the NimbleGen
arrays.
2.3.1 Spatial Artifacts
Stage 1 of the proposed algorithm is targeted at specific technical covariates such as
melting temperature, reference channel artifacts, and spatial artifacts. To demonstrate
the effectiveness of technical covariate LOESS normalization in removing spatial artifacts,
Figure 2.2 shows log2 intensity ratios of two arrays before and after LOESS normalization.
It can clearly be seen that the majority of spatial artifacts are removed and the expected
random patterns of amplifications and deletion are observable. Note that the ability of
LOESS normalization to remove very sharp local biases such as the scratch seen on the
right of Figure 2.2.a) is limited due to the limited flexibility of the algorithm at reasonable
numbers of degrees of freedom. Although the effect of the scratch could be dampened, it
could not be removed completely.
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2.3.2 Derivative Log2Ratio Spread
Table 2.2 summarizes DLRS as well as mean efficiency estimates for each dataset and
normalization method. The proposed pcaCGH approach reduces DLRS significantly and
outperforms existing methods by up to an order of magnitude in terms of efficiency.
Especially striking is the improvement over the commonly used quantile normalization
approach for the Agilent data sets. While quantile normalization seems to increase the
DLRS, the pcaCGH method achieves a similar reduction in DLRS as in the NimbleGen
data set.
Table 2.2. Derivative Log2Ratio Spread: Comparison of DLRS estimates and mean
algorithm efficiency
Dataset Method DLRS 95% CI DLRSe 95% CI
Agilent
Processed Signal 0.176 (0.170,0.182) N/A N/A
pcaCGH 0.110 (0.105,0.116) 0.366 (0.334,0.398)
quantile 0.183 (0.176,0.190) -0.041 (-0.059,-0.023)
popLowess 0.171 (0.165,0.176) 0.030 (0.021,0.039)
WACA 0.170 (0.164,0.175) 0.035 (0.026,0.043)
Agilent Dye Swap
Processed Signal 0.174 (0.167,0.182) N/A N/A
pcaCGH 0.114 (0.109,0.118) 0.334 (0.301,0.368)
quantile 0.180 (0.173,0.187) -0.039 (-0.065,-0.001)
popLowess 0.168 (0.161,0.175) 0.036 (0.030,0.043)
WACA 0.166 (0.159,0.173) 0.045 (0.035,0.055)
NimbleGen
Raw Signal 0.155 (0.149,0.161) N/A N/A
pcaCGH 0.104 (0.010,0.104) 0.316 (0.290,0.343)
quantile 0.145 (0.138,0.151) 0.065 (0.042,0.087)
popLowess 0.132 (0.124,0.140) 0.088 (0.067,0.110)
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2.3.3 Improvement in Signal to Noise Ratios
Table 2.4 summarizes signal to noise ratios for each normalization method and data set as
well as fold changes in signal to noise ratios with respect to the raw data. Signal to noise
ratios for each array and its corresponding dye swap were calculated in a similar way.
Table 2.3 lists fold changes in signal to noise ratios between Agilent’s original and dye
swap raw data and normalized data. The proposed pcaCGH method is the only approach
that consistently improves signal to noise ratios significantly, well above improvements (if
any) of existing methods.
Table 2.3. Mean fold change between signal to noise ratios for dye swaps
Method Mean FC 95% CI
pcaCGH 1.87 (1.66,2.09)
median 1.01 (1.01,1.02)
quantile 0.96 (0.94,0.98)
popLowess 0.90 (0.83,0.96)
WACA 0.99 (0.96,1.01)
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Table 2.4. Signal to noise ratios for technical replicates
Dataset Cell Line Method S/N Ratio Fold Change
Agilent A549
Processed Signal 12.60 N/A
pcaCGH 26.99 2.14
median 12.67 1.01
quantile 12.06 0.96
popLowess 12.88 1.02
WACA 14.34 1.14
Agilent Dye Swap A549
Processed Signal 18.42 N/A
pcaCGH 29.32 1.60
median 20.10 1.09
quantile 16.23 0.88
popLowess 18.39 1.00
WACA 20.11 1.09
NimbleGen
A549
Raw Signal 2.03 N/A
pcaCGH 7.04 3.47
median 5.42 2.67
quantile 5.67 2.79
popLowess 5.41 2.67
SF-268
Raw Signal 3.11 N/A
pcaCGH 8.15 2.62
median 6.61 2.12
quantile 6.78 2.18
popLowess 6.57 2.11
OVCAR-8
Raw Signal 5.07 N/A
pcaCGH 11.25 2.21
median 9.34 1.84
quantile 8.40 1.65
popLowess 8.14 1.61
30
2.3.4 Improvement in Agreement between Technologies
Table 2.5 shows the mean correlation across cell lines between log2 ratio intensities from
different platforms before and after normalization. While all normalization approaches
improved correlations significantly, the pcaCGH approach outperformed existing methods
easily. Furthermore, the variance in differences between corresponding probes from both
platforms could be reduced by up to 45% while the next best method popLowess could
only reduce the variance by up to 14% (see Table 2.6). Lastly, a similar increase in
proportion of matching probes with the same detection call, i.e. matched pairs of probes
from different platforms that were both called a deletion, amplification, or neither, was
observed across normalization procedures (see Table 2.7).
Table 2.5. Agreement between technologies: Mean correlations between NimbleGen
and Agilent probe intensities for normalization methods used
Agilent/NimbleGen Agilent DS/NimbleGen
Method Mean Correlation 95% CI Mean Correlation 95% CI
Raw Data 0.08 (0.06,0.09) 0.07 (0.05,0.09)
pcaCGH 0.50 (0.46,0.53) 0.49 (0.45,0.52)
median 0.35 (0.32,0.38) 0.35 (0.31,0.38)
quantile 0.37 (0.34,0.40) 0.37 (0.34,0.39)
popLowess 0.39 (0.36,0.42) 0.39 (0.36,0.42)
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Table 2.6. Variance explained in log2 ratio intensity differences between technologies
Agilent/NimbleGen Agilent DS/NimbleGen
Method Var. Explained 95% CI Var. Explained 95% CI
pcaCGH 0.12 (0.08,0.16) 0.13 (0.10,0.16)
median 0 N/A 0 N/A
quantile 0.06 (0.03,0.8) 0.07 (0.04,0.10)
popLowess 0.02 (0.01,0.4) 0.03 (0.01,0.05)
Table 2.7. Proportion of Probes in Agreement (PPA)
Agilent/NimbleGen Agilent DS/NimbleGen
Method PPA PPA
raw data 0.53 0.55
pcaCGH 0.72 0.72
median 0.72 0.73
quantile 0.76 0.76
popLowess 0.67 0.67
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2.3.5 Improved Resolution of Called Segments
Figure 2.4 shows detection calls for parts of chromosome 17 of cell line SK-MEL-5 for the
Agilent dataset where blue lines represent calls for the raw and green calls for normalized
log2 intensity ratios. It can be seen that regions of called copy number aberrations are
shorter and more frequent indicating an increased resolution. Table 2.8 quantifies this first
impression by listing the performance measures introduced in Section 2.2.3. The shorter
median aberrant region lengths after normalization indicate that along with the expected
long regions of copy number aberrations, there are also many more short regions present
in cancer cell lines that have not been detected due to low signal to noise ratios in the
raw data and that cannot be picked up by normalizing with existing methods. Further
evidence of improved resolution can be seen in Figure 2.5, which shows density plots
of intensity ratios before and after normalization for cell line OVCAR-8 in the Agilent
dataset. While only two clear peaks are distinguishable in pre-normalized data, three
clear peaks that are significantly sharper are present in post-normalized data.
Furthermore, the MMAS estimates for segmented data normalized by the proposed
pcaCGH method are not significantly smaller than those from either segmented raw data
or those from segmented data normalized with existing method. The lack of reduction in
dynamic range together with similar proportions of probes called aberrant across normal-
ization methods is strong evidence that the pcaCGH approach does not remove biological
relevant information.
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Table 2.8. Improvement in Resolution: Median aberrant region length (MARL),
proportion of probes called aberrant (PPCA), and median MAD across all cell lines
after segmentation (MMAS)
Dataset Method MARL PPCA MMAS
Agilent
Processed Signal 123 0.74 0.2815
pcaCGH 63 0.76 0.3041
median 122 0.73 0.2819
quantile 163 0.76 0.2648
popLowess 96 0.59 0.3011
WACA 115 0.70 0.2497
Agilent Dye Swap
Processed Signal 108 0.74 0.2959
pcaCGH 61 0.76 0.2617
median 109 0.72 0.2846
quantile 139 0.71 0.2532
popLowess 83 0.59 0.2865
WACA 95 0.69 0.2356
NimbleGen
Raw Signal 277 0.76 0.1621
pcaCGH 92 0.57 0.1779
median 245 0.57 0.1695
quantile 197 0.59 0.1888
popLowess 185 0.55 0.1789
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Figure 2.4. Visualization of Pre- and Post-normalized Data: Raw and Normalized
Data for a Segment of Chromosome 17 of Cell Line SK-Mel-5
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Figure 2.5. Density Plots of Signal Intensities Before and After Normalization:
Density plots for cell line OVCAR-8 are shown pre- and post-normalization.
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2.3.6 Interpretation and Utility of LOESS Regression and Prin-
cipal Components
To illustrate the utility of the LOESS regression and the PCA step in the proposed
algorithm, the loadings of the strongest principle component recovered from each data
set and their correlation to GC content as a known technical covariate were investigated.
To that end, the PCA step was applied directly to the raw NimbleGen data without
performing LOESS normalization first. Figures 2.6 and 2.7 show each probe’s loading
against its GC content recovered from the raw and LOESS normalized NimbleGen data,
respectively. The corresponding correlations between loadings and GC content were 0.247
and 0.071, respectively, indicating that the LOESS normalization does reduce systematic
variability due to technical covariate and also that the PCA step does pick up that same
variability if not already removed in step 1 of the algorithm. These observations and
the previous work on PCA like methods beg the question of whether the LOESS step is
needed at all. This was addressed by computing DLRS and DLRSe measures without
the initial LOESS step. The DLRS and DLRSe for the normalized data obtained from
applying the PCA step directly to the raw NimbleGen data is 0.136 and 0.111 while
the DLRS and DLRSe of the PCA step applied to the LOESS normalized data is 0.104
and 0.316, respectively. This shows that both LOESS regression and PCA contribute
substantively to reducing systematic variability. It was also of interest to verify that
neither the LOESS regression nor the PCA step are picking up significant amounts of
biological signal. If that were the case, one would expect that high principal component
loadings would cluster on a few genomic positions. Figures 2.8 and 2.9 show the loadings of
the first principle components by genomic position for Agilent and NimbleGen data while
Figure 2.10 shows the LOESS residuals against genomic position for the NimbleGen data.
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None of these three figures do show chromosome location patterns in the distribution of
the loadings suggesting that biological signal is not a major component of the variance
removed.
Note that the loadings were highly reproducible for the replicated Agilent data sets with a
correlation of 0.647 (see Figure 2.11). Furthermore, the NimbleGen data set was randomly
divided into two sets of 36 arrays and performed the PCA step on both data sets separately.
The resulting loadings of the first principal components were moderately correlated with
a correlation of 0.384 (see Figure 2.12).
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Figure 2.6. Scatter plot of each probe’s first principle component loading against its
GC content where the PCA step was applied directly to the raw NimbleGen data. The
correlation between the PC loadings and GC content is 0.247.
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Figure 2.7. Scatter plot of each probe’s first principle component loading against its
GC content where the PCA step was applied to the LOESS normalized NimbleGen
data. The correlation between the PC loadings and GC content is 0.071.
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Figure 2.8. Scatter plot of each probe’s first principle component loading against its
genomic position for the Agilent data set.
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Figure 2.9. Scatter plot of each probe’s first principle component loading against its
genomic position for the NimbleGen data set.
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Figure 2.10. Scatter plot of each probe’s LOESS residual against its genomic position
for the NimbleGen data set.
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Figure 2.11. Scatter plot of each probe’s first principle component loading for Agilent
and Agilent Dye Swap data sets. The correlation between the loadings is 0.647.
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Figure 2.12. Scatter plot of each probe’s first principle component loadings for
randomly divided NimbleGen data sets (36 arrays each). The correlation between the
loadings is 0.384.
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2.4 Discussion
Detecting copy number aberration has become an integral part of uncovering the under-
lying processes of many genetic diseases and is becoming more prevalent in personalized
patient care [65]. Array CGH technology has enabled researchers to investigate copy num-
ber aberrations across the whole genome in a high throughput fashion with an improved
resolution, a higher dynamic range, and a convenient way to access the data. While large
fold changes can be easily detected using standard methods to analyze the raw data, many
scientists suspect that shorter and more subtle copy number changes play an important
role in many genetic disorders. Microarray experiments involve numerous complex proce-
dures including DNA extraction, DNA hybridization, and image scanning, that contribute
to non-biological variation. Standard methods do not adjust for the technical error sources
and therefore lack the resolution to reliably detect those subtle changes and thus more
sophisticated approaches are needed.
A method called pcaCGH was proposed to normalize aCGH data using technical co-
variates and a robust PCA. Qualitative and quantitative evidence showing the efficiency
of the proposed algorithm was presented. Furthermore its performance was compared to
existing methods commonly used for normalization of aCGH data and it was shown that
the pcaCGH approach significantly improves on those methods.
A good measure of how well a normalization method performs is how well the biologi-
cal differences stand out above the ’noise’ of differences due to factors other than biology.
This ’technical noise’ is believed to be mostly systematic bias due to variation in technical
aspects of processing the samples. The technical noise due to variation in technical aspects
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of sample processing is well measured by the differences between replicate arrays which
measure the same sample relative to the differences between arrays measuring different
samples, which are compounded of biological differences and technical noise. Therefore the
ratio of the variance across biologically distinct samples, relative to the variance between
replicate samples, is a good measure of how well a normalization method has succeeded in
its goals. Note that by construction the procedure reduces overall variance in a dataset;
however it is not believed that the proposed procedure simply reduces variation. It was
shown that the ratios of variance attributable to combinations of biological and techni-
cal variation, to the differences attributable solely to technical variation, are significantly
better after applying the proposed algorithm than without normalization as well as better
than after applying existing normalization procedures.
Using this metric on technical replicates as well as dye swap replicates, it was demon-
strated that the proposed method significantly increases signal to noise ratio in comparison
to existing methods. The increase in signal to noise ratio seem to lead to a higher res-
olution, i.e. the ability to detect smaller copy number changes, which is apparent when
comparing median lengths of aberrant regions. Thus the proposed algorithm allows for a
more detailed picture of copy number structure across the whole genome. Furthermore
it was shown that while technical noise is reduced significantly the dynamic range is pre-
served.
Another strong argument for the proposed algorithm is an improved agreement across
platforms. To date, few previous analyses have investigated concordance between dif-
ferent aCGH technologies. Compelling evidence was presented that the algorithm not
only increases signal to noise ratios significantly, but also notably improves agreement
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between Agilent and NimbleGen data well above above improvements existing methods
can achieve.
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Chapter 3
Assessment of Current Methods for
Analyzing RNA-Seq Studies
3.1 Introduction
As mentioned in the introduction, the decrease in cost per Megabase sequenced and the
increase in throughput let to a significant increase in NGS datasets. The following two
chapters focus on the analysis of quality assured data obtained from RNA-Seq studies
investigating transcription levels through some form of experimental design. The main
advantage of RNA-Seq over microarrays for gene-expression studies is a higher dynamic
range as the only limiting factor for genes expressed at low levels is the number of total
reads obtained from the mRNA sample, which correlates to the total cost of a study,
while the lack of background noise due to cross hybridization as in microarray experi-
ments allows detection of weaker signals [106]. Furthermore, scientists do not have to rely
on probe annotations supplied by manufacturers anymore since the sequence of cDNA
molecules derived from the mRNA sample is obtained directly and can then be aligned to
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the scientist’s reference sequence or gene model of choice. Theses advantages have lead to
numerous RNA-Seq studies on a variety of organisms and cell types [24]. Scientists most
commonly look for differences in transcription levels for genes, where a gene is defined as
the union of its exons and this definition will be adopted for the following two chapters.
However, the methods described to analyze gene-level data could also be applied to exon-
by-exon analyses or any other analysis that summarizes reads aligning to a pre-specified
genomic region into count data as demonstrated in Chapter 5.
A natural choice to analyze count data is the Poisson distribution. Marioni et al. [51]
first investigated the properties of RNA-Seq data and concluded that the Poisson distri-
bution is suitable to describe count data obtained from sequencing technical replicates,
i.e. sequencing the same RNA sample repeatedly. However, it became clear very quickly
that the Poisson distribution could not explain extra variation seen in the data when
sequencing biological replicates, i.e. sequencing RNA samples extracted from the same
tissue but from separate individuals [16, 60, 86]. A natural extension to the Poisson distri-
bution is the negative binomial (NB) distribution that models extra variation above that
expected from a Poisson distribution through an additional parameter called the overdis-
persion parameter. Two methods, DESeq by Anders et al. [3] and edgeR by Robinson
et al. [87], based on the NB distribution have been adopted by the scientific community
as preferred approaches to analyze RNA-Seq data. Both approaches use some form of
information sharing across genes (see Sections 3.2.1 and 3.2.2) and were initially devel-
oped to simply detect differences between two groups of samples, e.g. RNA samples from
individuals with a specific disease and normal controls. As experimental designs have
recently become more complex, these methods were recently extended to handle potential
confounders in addition to the covariate of interest. To date, there has not been an evalu-
ation of these extensions’ performance with regards to type I error control and power and
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the purpose of this chapter is to extensively test DESeq and edgeR across a wide range of
scenarios and data structures through simulations and application to real data. The ex-
isting methods are also compared to a newly proposed method to introduced in Chapter 4.
3.2 Methods
The following sections summarize briefly the approaches by Anders and Huber [3], imple-
mented in the R package DESeq, and Robinson et al. [87], implemented in the R package
edgeR, and also outline the strategy to evaluate those methods. R version 2.14 (released
on 10/31/2011), DESeq version 1.6.0 and edgeR version 2.4.0 were used to obtain the
results presented in this study. Standard settings as described in the package’s vignettes
were used and the an example of the R code used to obtain presented results can be found
in Appendix C. Both methods are currently considered the “gold-standard” in analyzing
RNA-Seq data and were evaluated by performing extensive simulation studies under a va-
riety of scenarios as well as applying the methods to publicly available datasets and data
obtained from a RNA-Seq experiment conducted at Virginia Commonwealth University.
3.2.1 edgeR
Robinson et al. have developed their software edgeR [87] to analyze count data from high
throughput sequencing studies based on previous papers by Smyth and Verbyla [97] as
well as Robinson and Smyth [86]. Their model is based on the negative binomial (NB)
distribution with probability mass function (pmf)
fNB(y|r, p)
(
y + r − 1
k
)
(1− p)rpk, (3.1)
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for k = 0, 1, 2, . . ., p ∈ (0, 1) and r > 0. Here E(Y ) = µ = pr
1−p and V ar(Y ) = σ
2 = pr
(1−p)2 .
The distribution can be re-parameterized in terms of µ and σ2:
fNB(y|µ, σ2) =
(
y + µ2/(σ2 − µ)− 1
µ2/(σ2 − µ)− 1
)
(µ/σ2)µ
2/(σ2−µ)(1− µ/σ2)y, y ≥ 0, µ ≥ 0, σ2 > 0.
(3.2)
Note that the NB distribution is equivalent to the Poisson distribution when σ2 = µ.
Furthermore, let lNB(µ, σ
2|y) denote the likelihood function of the NB distribution. The
mean value µij of the observed counts for gene i, i = 1, . . . , I, and sample j, j = 1, . . . , J ,
is parameterized as
µij = qi,ρ(j)sj, (3.3)
where qi,ρ(j) is proportional to the expected value of the true (but unknown) concentration
of fragments from gene i under condition ρ(j) and sj represents a normalizing factor based
on the total number of reads from sample j compared to total number of reads from the
other samples. The authors define the variance the commonly used parameterization
σ2ij = µij + θiµ
2
ij where θi is called the dispersion parameter. Assuming equal library sizes
for all samples, the authors estimate the dispersion θi for gene i by weighted conditional
maximum likelihood:
WL(θi) = li(θi) + αlC(θi), (3.4)
where θi is the genewise conditional log-likelihood derived in [86] and lC(θi) =
∑I
i=1 li(θi)
is the common likelihood over all genes. Since the assumption of equal library sizes is
unattainable for real HTS studies, Robinson et al. use a method called quantile adjusted
conditional maximum likelihood (qCML). Quantile-adjusted CML uses an iterative al-
gorithm to estimate θi that adjusts observed counts as if all observations come from a
NB(qi,ρ(j)s, σ
2
ij) distribution where s is the geometric mean of the library sizes sj, i.e.
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s =
(∏J
j=1 sj
) 1
J
.
The parameter α, estimated using an empirical Bayes procedure, determines how much
a gene’s dispersion estimate based on its counts alone is shrunken towards a common
dispersion estimate θˆC obtained by maximizing lC . If α = 0 then the likelihood of that
gene’s data is maximized while if α is sufficiently large, the estimate for θi is close to the
estimate of a common dispersion θC . The Bayes procedure assumes that θˆi|θi ∼ N(θi, τ 2i )
and θi ∼ N(θ0, τ 20 ). The author’s strategy to estimate α relies on choosing α such that
WL(θi) coincides with an empirical Bayes rule using the posterior mean estimator of θi:
θˆBi = E(θi|θˆi) =
θˆi/τ
2
i + θC/τ
2
0
1/τ 2i + /τ
2
0
, (3.5)
where the hyperparameters θ0 and τ
2
0 can be estimated from the marginal distribution of
θˆi. For a detailed derivation of the approach, please refer to the author’s original papers.
Robinson’s method has been extended to generalized linear models (GLMs) [62] using
Cox-Reid approximate conditional inference [20] to estimate dispersion and use those
values to fit NB models to each gene using their own fitting procedure. GLMs are used
to model the relationship between mean µij and explanatory variables through a link
function g:
g(µij) = g(qijsj) = βi0 + βi1xj1 + . . .+ βipxjp = xjβi, (3.6)
where X1, . . . , Xp represent either covariates of interest or confounders that need to be
adjusted for. Note that the rate qij for gene i and sample j does now not only depend
on conditions ρ(j) as proposed originally by Robinson et al. in Equation 3.3, but rather
on the values of all p covariates of that sample. The most commonly used link function
is the log link, which is used as link function of choice for all models presented hereafter
in this work. The software supplies p-values for testing differential expression based on
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standard likelihood ratio tests (LRTs).
3.2.2 DESeq
Anders et al. [3] also based their work on the NB distribution described in Equation 3.2
where µij = qi,ρ(j)sj is similarly defined as in edgeR. The variance σ
2
ij however is defined
by the authors as a sum of a “shot noise“ term and a raw variance term:
σ2ij(qi,ρ(j)) = sjqi,ρ(j) + s
2
jνρ(qi,ρ(j)) = µij + s
2
jνρ(qi,ρ(j)). (3.7)
Note that the term shot noise is not used properly here as it not depend on magnitude
of the actual signal, which in this case is qi,ρ(j). Furthermore note that Anders et al.
assume that the per-gene raw variance parameter νρ(j) is a smooth function of qi and ρ(j)
and consequently the variance σ2ij is a function of these parameters. This assumption
is designed to obtain more precise estimates of the variance for gene i using data from
genes with similar gene expression. In general, Anders et al. fit the smooth function νi,ρ(j)
empirically by first estimating qi,ρ(j) and σ
2
ij and then fitting a smooth curve through
those estimates. The smooth curve was first fit using a local regression but now uses a
parametric form as default fitting procedure. Specifically, the parametric form is given by
σ2ij(qi,ρ(j)) = a0 +
a1
sjqi,ρ(j)
, (3.8)
where a0 and a1 are estimated using a robust gamma-family GLM.
Their algorithm to fit the proposed model and estimate all parameters is described in
great detail in [3] using the functional relationships described in Equations 3.7 and 3.8.
Two options are available in DESeq to fit the mean-variance relationship proposed in
Equation 3.7. The first approach estimates the variance for each gene without taking
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into account each sample’s group membership, i.e. νi,ρ(j) = νi, enabling this approach
to be applied to data without biological replicates. The second approach first calculates
variance estimates within each condition and then pools the estimates across conditions
taking into account biological variation. The two approaches are labeled ”blind” and
“pooled” dispersion estimation.
Using Equation 3.6, Anders et al. have since extended both approaches for use with GLMs
using a custom negative binomial family implementing Equation 3.7 in conjunction with
R’s glm function. DESeq also offers an ad hoc adjustment to dispersion estimates called
”sharing” modes. The first mode labeled fit-only uses the variance estimate obtained
by using the proposed algorithm to estimate the variance parameter σ2ij. The second
mode labeled maximum estimates σ2ij using the proposed method as well as the variance
estimator used to fit νi,ρ(j) and proceeds using the maximum of the two variance estimates
in subsequent analyses. Note that there does not seem to be a theoretical justification why
this adjustment is needed, but rather relies on empirical observations made by the authors
that using sharing mode fit-only can lead to false positives as mentioned in the help file for
the package. Two methods were evaluated and will be referred to as DESeq Liberal and
DESeq Conservative, respectively. DESeq Liberal uses “blind“ dispersion estimation and
sharing mode fit-only while DESeq Conservative uses pooled dispersion estimation and
sharing mode maximum. The software supplies p-values for testing differential expression
based on standard LRTs.
3.2.3 Simulation Studies
The simulation studies were designed to test the methods under realistic scenarios. To
that end, two publicly available datasets were used. The first contained RNA-Seq count
data on humans, chimpanzees, and rhesus macaques using liver RNA samples from three
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males and three females from each species [12] and was downloaded from the NCBI Gene
Expression Omnibus [6] under accession number GSE17274. The dataset contained counts
for 17,254 genes. Count data for 12,410 genes expressed in human B-cell RNA samples
of 17 females and 24 males sequenced by Cheung et al.[18] was downloaded from the
ReCount database [24]. Since we do not know the true underlying distribution of the
dispersion parameters, the datasets were used to obtain four sets of dispersion estimates
using the following algorithms:
1. edgeR’s tagwise Cox-Reid dispersion estimation algorithm,
2. DESeq’s blind dispersion estimation algorithm with sharing mode fit-only,
3. DESeq’s pooled dispersion estimation algorithm with sharing mode maximum, and
4. maximum likelihood estimation using Ripley’s and Venables’ theta.ml R function
[105].
The four sets of dispersion estimates were then taken to be the true underlying distribution
of dispersion parameters and together with the estimated mean count for each gene were
used to create four simulation scenarios. Figures 3.1 and 3.2 illustrate the relationship
between mean-dispersion relationship for the four scenarios. By design, DESeq prescribes
a functional relationship between mean and dispersion while the correlation between mean
and dispersion for edgeR and ML dispersion estimates is significantly weaker.
Sixty-four datasets each with sample size 18 for the Marioni data and sample sizes
of 41, 18, 15, 12 and 9 for the Cheung data were simulated using the four simulation
scenarios described above. To assess power, 10% of genes were randomly chosen to have
log fold changes drawn from a N(0, 2) distribution and those fold changes were used to
generate gender differences. For each dataset, the three methods were used to obtain p-
values testing for gender differences. The proportion of genes with true gender differences
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Scenario 1 Scenario 2
Scenario 3 Scenario 4
Figure 3.1. Dispersion estimates against mean gene count on a log scale
for the Marioni dataset
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Scenario 1 Scenario 2
Scenario 3 Scenario 4
Figure 3.2. Dispersion estimates against mean gene count on a log scale
for the Cheung dataset
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called significant at a 10% false discovery rate (FDR) after Benjamini-Hochberg multiple
comparison correction [7] was used as an estimate of power. Additionally, a categorical
covariate with three levels distributed evenly across gender was included in each model and
was used to assess type I error. The size of each test at a 0.001 level was calculated as the
proportion of genes with p-values smaller than 0.001 where genes for which the models did
not converged were disregarded. Furthermore, the number of genes called significant at a
10% false discovery rate (FDR) after Benjamini-Hochberg multiple comparison correction
was recorded.
3.2.4 Application to Internal and Publicly Available Datasets
Gender-specific gene expression has been studied extensively over the last years [66, 95,
104, 110, 112]. These studies have shown that the vast majority of genes showing evi-
dence for gender-specific gene expression are located on chromosome Y, few are located on
chromosome X, and rarely any are located on autosomal chromosomes. Therefore testing
for gender-specific gene expression is well suited to compare methods in terms of false
positive rate and power on real data.
In addition to the Marioni primate dataset and the Cheung HapMap dataset, one ad-
ditional publicly available dataset and one additional internal dataset with phenotypic
information on gender were used. The public dataset is a subset of the Marioni primate
dataset that was re-aligned and summarized by Frazee at al. [24] and is available from the
Recount database under the name “Gilad“. This dataset contains count data on 10,525
genes for three male and three female samples. The internal dataset from Xiangning
Chen’s lab at Virginia Commonwealth University contained count data on 21,134 genes
for 82 sequenced brain samples from normal controls (n=26) and patients with bipolar
disorder (n=25) or schizophrenia (n=31). The Chen data included information on age,
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brain pH, and post mortem interval (PMI), which were used as covariates during model fit-
ting in addition to gender and diagnostic group. Furthermore, to generate a dataset with
smaller sample size, a subset was taken from the Cheung dataset by randomly choosing
ten male and ten female samples.
3.3 Results
Supplementary Table A.1 and Figure 4.2 show average size estimates at the 0.001 signifi-
cance level as well as average and maximum number of genes called significant at a 10%
FDR cutoff over 64 simulated datasets. It can be seen that edgeR and DESeq Liberal
only control the size of the test under one scenario. In the worst case, size estimates
for edgeR and DESeq Liberal are up to 3-fold and 8-fold over nominal size. This leads
to a significant number of false positives when applying a FDR procedure as shown in
Supplementary Table A.2 and Figure 4.3. To further evaluate the reason for the increased
number of false positives, the dispersion estimates were compared to the true dispersion
values used to simulate the data. Figures 3.3.a and 3.3.b show dispersion estimates from
edgeR and DESeq Liberal, respectively, against the true dispersion values in blue on a
log scale over 64 simulations for scenario 4. Red points indicate the average dispersion
estimate for a specific gene while green points indicate average dispersion estimates for
genes falsely identified as differentially expressed. The plots show that for the overwhelm-
ing majority of genes falsely called differentially expressed the dispersion estimate was
smaller than the true dispersion value. It was also of interest whether false positives oc-
cur only for genes expressed at high levels, low levels or a mixture of both. Figure 3.4
shows true dispersion values against mean gene count in black on a log scale for scenario
4. Red points indicate mean dispersion estimates obtained from DESeq Liberal over 64
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simulations while magenta points indicate false positives, which seem to occur for the
entire range of mean gene counts. The size estimates for DESeq Conservative were found
to be below nominal level for the majority of scenarios and sample sizes. However, for
scenario 4 and small sample sizes, size estimates were increased 2-fold above nominal level.
Similar observations to those made in the simulation studies could be made when both
methods were used to test for gender-specific gene expression in real data. Table 4.4 shows
the number of genes called differentially expressed at a 10% FDR cutoff after Benjamini-
Hochberg multiple comparison correction. DESeq Liberal identifies a significant number
of genes not located on chromosome Y and also identify genes on chromosome X that
are not known to show gender-specific expression for all datasets while edgeR performs
well for the Chen data, but not for the remaining datasets. DESeq Conservative is more
conservative, but also identifies a number of false positives for the Gilad dataset, which
features a small sample size.
3.4 Conclusions
The evaluation of methods using moderation when estimating the dispersion parameter
for a NB distribution has shown that DESeq Liberal and to a lesser extend edgeR have
significant problems to control type I error under certain scenarios. An explanation for
increased false positive rates was given by showing that these methods underestimate the
dispersion parameter for a subset of genes. DESeq Conservative is conservative for the
majority of scenarios and sample sizes tested, but also tends to increased false positive
rates when sample sizes are small. In Chapter 4 a new algorithm will be proposed that
does not use moderation and can handle categorical and continuous covariates. It will be
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shown that this algorithm maintains size under a variety of scenarios and has comparable
or better power for sample sizes of twelve or larger when compared to existing methods.
The results obtained in this chapter will be put into further perspective in Section 4.4.
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ab
Figure 3.3. Dispersion estimates against true dispersion value on log scale
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Figure 3.4. Dispersion values against mean gene count on a log scale
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Chapter 4
Analyzing RNA-Seq Studies Using a
Negative Binomial Model with
Zero-inflated Component
4.1 Introduction
Gene expression analyses utilizing data obtained through sequencing of RNA molecules
(RNA-Seq [58, 60]) have gained widespread popularity over the last years. Due to the
high costs of sequencing when first introduced, early RNA-Seq studies employed very
simple experimental designs, i.e. compared a small number of biological replicates across
two conditions without regards for potential confounders. The two most popular software
packages DESeq [3] and edgeR [87] described in Sections 3.2.1 and 3.2.2 to analyze RNA-
Seq data were designed to analyze studies with few biological replicates by leveraging
information across genes. As sequencing costs decrease rapidly [40], more complex, and
ultimately more interesting, experimental designs can be utilized to investigate biological
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questions of interest. For example, due to its complexity, the Chen dataset introduced in
Section 3.2.4 requires the inclusion of several covariates such as age, gender, brain pH,
and PMI in addition to diagnostic group, which is the covariate of interest. The Marioni
dataset introduced in Section 3.2.3 has multiple biological replicates for males and females
across three species. A subset of a recently published gene expression study by Kang et
al. [37] using exon arrays to investigate the development of the human brain across 32
brain regions is currently being sequenced using RNA-Seq to investigate differences in
gene expression profiles across several brain regions. Covariates such as brain pH, PMI,
age and gender played an important role in the original study and will need to be adjusted
for in the RNA-Seq study as well. The emergence of these complex RNA-Seq datasets
stresses the need for models that can handle additional covariates.
The GLM framework introduced in Section 3.2.1 is well suited for complex datasets. Con-
sequently, Robinson et al. and Anders et al. extended their methods to handle additional
covariates using the GLM framework. As outlined in Chapter 3, these methods seem to
have trouble with controlling type I error under certain realistic scenarios.
More complex datasets have also unearthed an additional phenomenon that affects
a subset of genes. Consider Figure 4.1 that shows a heatmap of counts for a subset of
genes of the Marioni dataset. It can be seen that there are a number of genes for which
there are many samples with zero counts (blue color) while other samples have counts
between 70-1,000 (red color). These large differences do not seem to correlate with gender
or species differences for the majority of genes and therefore a GLM with gender and
species as explanatory variables will not be able to explain the variance present for these
genes.
In statistics this property is called zero-inflation, i.e. having more zero counts than
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Figure 4.1. Heatmap of counts for Marioni dataset
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one would expect from a NB distribution with given mean and dispersion. To further
quantify to what degree and how many genes are affected, simulation studies using NB
models with mean gene counts obtained from the Chen, Marioni, and Cheung datasets
and the four sets of dispersion estimates described in Section 3.2.3 were conducted to
determine the proportion of genes with zero counts above the expected number of zero
counts. One thousand datasets were simulated for each scenario and original dataset and
the number of zeros occurring for each gene were recorded. For each gene an empirical
p-value for the number of zeros occurring in the original dataset was computed as the
proportion of simulated datasets that showed more zeros than the observed zero count.
Table 4.1 lists the proportion of genes with empirical p-values smaller than 0.001 for three
datasets across all four scenarios. One would expect of course that 0.1% of the genes
have empirical p-values of 0.001 or smaller. The results of the simulation studies however
indicate that between 0.7% and 5% of genes could be affected depending on the true
underlying distribution of dispersion parameters and the structure of the dataset.
Table 4.1. Proportion of genes with empirical p-values smaller than 0.001
Dataset Scenario 1 Scenario 2 Scenario 3 Scenario 4
Chen 0.05 0.03 0.02 0.01
Cheung 0.017 0.016 0.009 0.007
Marioni 0.023 0.019 0.011 0.012
Furthermore, a NB GLM and a NB GLM with additional zero-inflation parameter
(see Section 4.2.1 for more detail) were fit to the Chen, Cheung, and Marioni datasets
and the Akaike information criterion (AIC [2]) for both models was recorded. Since
AICNB − AICZINB − 2 is distributed according to a χ2−distribution with one degree of
freedom, a p-value that quantifies how much the extra parameter in the zero-inflated NB
model improves the fit of the model can be obtained. Table 4.2 lists the number of genes
with moderate (p-value<0.2) and strong (p-value<0.05) evidence for an improved model
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fit among genes for which AICZINB was smaller than AICNB.
Table 4.2. Number of genes with AIC differences showing moderate and strong
evidence for improved model fit among genes for which AICZINB was smaller than
AICNB
Dataset Total P-value<0.2 P-value<0.05
Chen 1074 477 206
Cheung 749 244 123
Marioni 424 250 107
A zero-inflated NB model was introduced by Rashid et al. [78] to identify genomic
regions enriched in ChIP-seq and DNA-Seq data. In this chapter a comprehensive method
fitting a NB GLM with zero-inflation component is proposed that improves upon existing
methods with regards to type I error control while maintaining similar or better power for
a range of sample sizes for RNA-Seq studies. The zero-inflation component also improves
power for the subset of genes identified above. The method is called gamSeq as it is based
on a fitting algorithm used to fit generalized additive models (GAM) for location, scale,
and shape introduced by Rigby and Stasinopoulos [84]. The statistical properties of the
proposed model are evaluated and compared to existing methods for analyzing RNA-Seq
data.
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4.2 Methods
4.2.1 Negative binomial model with zero-inflated component
Using the GLM framework introduced in Section 3.2.2 and the parameterization used
by edgeR, i.e. µij = qijsj and σ
2
ij = µij + θiµ
2
ij , the following negative binomial model
with zero-inflation component (ZINB) is proposed to analyze RNA-Seq studies with more
sophisticated experimental designs:
fZINB(yij|µij, θi,xj ,βi, pii, sj) = pii ∗ I0(yij) + (1− pii) ∗ fNB(yij|µij, θi,xj ,βi, sj), (4.1)
where y = 0, . . . , 1; j = 1, . . . , N ; i = 1, . . . , I and
• pii ∈ [0, 1] is unobserved probability of belonging to the point mass component of
zero counts,
• I0(yij) = 1 if yij = 0 and I0(yij) = 0 if yij > 0),
• fNB(y|µij, θi,xj ,β, sj) is the negative binomial pmf with log link function
log(µij) = log(qijsj) = log(sj) + βi0 + βi1xj1 + . . .+ βipxjp = log(sj) + xjβi. (4.2)
Recall that X1, . . . , Xp represent either covariates of interest or confounders that need to
be adjusted for and log(sj) is used as a constant offset to adjust for total number of reads
for sample j in the model statement. Note that for pi ≡ 0, fZINB ≡ fNB.
Since the proposed model only ought to be used when evidence for zero-inflation exists,
the following algorithm is proposed to obtain parameter estimates for pii,βi, and θi for
gene i:
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1. Fit the NB model, i.e. set pii ≡ 0.
2. If at least one yij = 0, fit ZINB model.
3. If AICZINB < AICNB, use the parameter estimates and their estimated variance-
covariance matrix obtained from fitting the ZINB model. Otherwise, use the pa-
rameter estimates and their variance-covariance matrix obtained from fitting the
NB model.
4. Use the variance-covariance matrix of parameter estimates of the corresponding
model supplied by the fitting algorithm to test for significance of covariates of interest
using a Wald-type test.
Both models are fit using an algorithm by Rigby and Stasinopoulos [84] implementing
generalized additive models for location, scale and shape (gamlss) in their R package
gamlss [100]. The gamlss algorithm implements a wide variety of distributions and allows
all parameters of the distribution to be modeled as a combination of parametric and/or
additive nonparametric functions of explanatory variables as well as random-effect terms.
As shown in Equation 4.1, the ZINB distribution is defined by three parameters, the loca-
tion parameter µij, the scale (or dispersion) parameter θi and the zero-inflation parameter
pii. To achieve acceptable convergence rates in a timely and computational efficient man-
ner, the standard log link function shown in Equation 4.2 was used to model the location
parameter µij while no additional covariates were used to model the dispersion parameter
θi and zero-inflation parameter pii. The proposed algorithm will be referred to by gamSeq,
named after the accompanying R package, in the remainder of this text.
For the proposed model, Rigby and Stasinopoulos recommend the use of their own fitting
procedure introduced in [26] and [83]. For gene i, i = 1, . . . , I, contingent on the model
used, the algorithm maximizes the likelihood lZINB(βi, θi, pii|yi,X) or lNB(βi, θi|yi,X),
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corresponding to Equations 3.2 and 4.1 where yi = {yij}j=1,...,N and
X = {xjk}j=1,...,N ;k=1,...,p. An iterative Newton-Raphson algorithm is used to find the
maximum of the corresponding likelihoods using the observed information matrix. The
observed information matrix is also used to provide standard errors on parameter estimates
and standard Wald-type t-tests are used to test hypotheses for individual parameters. A
custom grid search is employed to find valid starting values. For a detailed description of
the fitting algorithm, please refer to Appendix B.2 in [84].
4.2.2 Model Assessment
To assess the performance of the proposed model, the same strategy outlined in Sec-
tions 3.2.3 and 3.2.4 was used. Four hypothetical true dispersion distributions based on
dispersion estimates obtained by using DESeq Conservative, DESeq Liberal, edgeR, and
ML estimation were used to simulate data according to a NB distribution. These sim-
ulation studies aim to evaluate the performance model with regards to type I error and
power of the proposed algorithm when the underlying distribution does not incorporate
any zero-inflation, i.e. under favorable conditions for the current approaches. Further-
more, scenarios 2 and 4 were used to simulate data according to Equation 4.1, i.e. a
negative binomial distribution with zero-inflation parameter pi. Values of 0.05, 0.1, 0.15,
and 0.2 based on simulation studies outlined in Section 4.1 were chosen for pi. Sixty-four
datasets were simulated for both scenarios using mean and dispersion estimates based on
the Cheung data and the size of the test at a 0.001 significance level, power at a 10%
FDR cutoff, and the number of false positives when testing for species differences were
recorded. The proposed model was also used to test for gender differences in the five
datasets described in Sections 3.2.3 and 3.2.4.
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4.3 Results
In this section the results from the simulation studies and application to real data de-
scribed in Section 4.2.2 are presented.
4.3.1 Statistical Properties
First the statistical properties of the proposed method are evaluated and compared to
existing methods. Supplementary Table A.1 lists size estimates at a 0.001 significance
level across the four different scenarios and datasets used and Figure 4.2 illustrates those
results. The horizontal red line in Figure 4.2 indicates the nominal level and bars above
the red line indicate increased type I error. In scenario 2, size estimates for all methods
are fairly close to nominal level and do not give reason for concern. In scenarios 1, 3 and 4
however, size estimates for edgeR are up to 2-fold, 3-fold and 4-fold above nominal level,
size estimates for DESeq Liberal are up to 5-fold and 8-fold above nominal level while size
estimates for DESeq Conservative are again at nominal level or below and size estimates
for gamSeq hover around nominal level. Supplementary Table A.2, listing the average
(maximum) number of false positives when testing for the categorical nuisance variable
included in the model using a 10% FDR cutoff, and Figure 4.3 provide further evidence
for increased type I error rates for edegR and DESeq Liberal for scenarios 1, 3, and 4.
Supplementary Table A.3 lists power estimates at a 10% FDR cutoff and Figure 4.4
shows power estimates against sample size for simulation studies based on the Cheung
data. Comparing power estimates for gamSeq to those for edegR and DESeq Liberal,
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Figure 4.2. Size estimates for simulation studies at 0.001 significance level. The red
line indicates nominal level.
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Figure 4.3. Median number of false positives when testing for species differences.
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Figure 4.4. Power against sample size for Cheung simulation studies.
gamSeq provides similar or better power down to sample size 15, a slight power loss at
sample size 12 and a significant loss of power at sample size 9 for scenarios 1, 2, and 3
while for scenario 4 gamSeq provides higher power down to sample size 15, similar power
for sample size 12 and a loss of power at sample size 9. Compared to DESeq Conservative,
gamSeq provides higher power for sample sizes of 15 or larger, comparable power at sample
size 12, and shows a moderate power loss at sample size 9 across all scenarios.
To further investigate the reason for the increased numbers of false positives for DESeq
Liberal and edgeR observed in scenarios 3 and 4, biases of dispersion estimates obtained
from the simulations studies of sample size 15 based on the Cheung dataset were calcu-
lated. As shown in Table 4.3, which lists the interquartile range (IQR) and median bias,
all four methods perform fairly well in recovering the true underlying dispersion where
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gamSeq slightly underestimates and the remaining methods slightly overestimate the true
dispersion. For genes that were wrongly identified by DESeq Liberal as differentially
expressed in scenarios 3 and 4 however, the median bias of DESeq Liberal’s dispersion
estimates was determined to be -3.09 and -1.83, respectively, while the median bias of
gamSeq’s dispersion estimates was calculated as -1.18 and -0.71, respectively. Similar ob-
servations could be made when looking at false positives identified by edgeR in scenarios
3 and 4 where the median bias for edgeR’s dispersion estimates was -1.79 and -1.018,
respectively, compared to a median bias of -1.25 and -0.72 for gamSeq’s dispersion esti-
mates. It has been shown by Hubbard and Allen [31] that the LRT has inflated type I
error when the overdispersion parameter θ is significantly underestimated. Thus, these
findings indicate that underestimated dispersion for a subset of genes under certain sce-
narios leads to increased type I error rates for DESeq Liberal and edgeR while gamSeq’s
estimates for these genes are less biased allowing for better control of type I error.
Table 4.3. Median bias and IQR obtained from simulated datasets of sample size 15
based on Cheung data structure
Scenario DESeq Liberal edgeR DESeq Conservative gamSeq
1
Median Bias 0.1470 0.0279 0.1588 -0.0777
IQR (-0.01,0.2654) (-0.0323,0.1214) (0.0344,0.4605) (-0.1982,-0.0191)
2
Median Bias 0.0695 -0.0057 0.0487 -0.0817
IQR (0.0629,0.1013) (-0.0542,0.0537) (0.0181,0.2758) (-0.1780,0.0100)
3
Median Bias 0.2212 0.0452 0.1697 -0.1146
IQR (0.1695,0.2944) (-0.1006,0.1550) (0.1496,0.4856) (-0.2469,-0.0573)
4
Median Bias 0.2391 0.0770 0.1989 -0.0597
IQR (0.0749,0.4603) (-0.0260,0.2565) (0.0997,0.7446) (-0.2218,-0.0132)
Finally it was of interest to determine whether there is a relationship between test
statistics and dispersion estimates. When testing for differential gene expression the
interest lies in detecting differences in population means, i.e. the null hypothesis µA = µB
is tested against the alternative hypothesis µA 6= µB for two populations A and B. This
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implies that the dispersion parameter θ in the negative binomial distribution is a true
nuisance parameter in the sense that it is not of interest for testing the null hypothesis.
Thus, a desirable statistical property is the ability to detect true differences in populations
means independently from the value of the overdispersion parameter θ. Therefore test
statistics should in principle be independent from dispersion estimates obtained from the
fitting procedure. Figures 4.5 and 4.6 show test statistics against dispersion estimates
for the Marioni and Cheung data. Systematic patterns can be observed for the DESeq
methods and to a lesser extend for edgeR while gamSeq does not show any relationship
between test statistics and dispersion estimates.
77
DESeq Liberal DESeq Conservative
edgeR gamSeq
Figure 4.5. Test statistics against dispersion estimates on log scale for
the Marioni dataset.
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DESeq Liberal DESeq Conservative
edgeR gamSeq
Figure 4.6. Test statistics against dispersion estimates on log scale for
the Cheung dataset.
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4.3.2 Application to internal and publicly available data
While simulation studies provide valuable insight into a method’s performance and ro-
bustness under various conditions, the ultimate goal is to analyze experiments designed
to answer biological questions of interest. To that end the proposed method was used to
test for gender differences using three publicly available datasets and one internal dataset
described in Sections 3.2.4 and 3.2.3. Table 4.4 shows the distribution of genes called
significant across chromosome Y, chromosome X, and autosomal chromosomes. For the
Chen dataset, the majority of genes identified to show evidence for gender specific gene
expression by DESeq Conservative, edgeR, and gamSeq are located on chromosome Y. All
genes located on chromosome X identified by gamSeq have been indicated to show gender
specific gene expression profiles by Xu at al. [110], Zhang et al. [112], and Preumont et
al.[73]. Genes identified by edgeR follow a similar pattern where four out of five genes lo-
cated on chromosome X overlap with those identified by gamSeq and therefore have been
indicated to show gender specific gene expression while the fifth gene and the two genes
located on other chromosomes have not been indicated before. DESeq Conservative and
gamSeq perform slightly better than edgeR as they identify more genes on chromosome
Y. DESeq Liberal performs worse with regards to false positives as the method identified
two genes on chromosome X and 18 genes on autosomal chromosomes that are not known
to show gender specific gene expression.
For the full Cheung dataset, DESeq Conservative and gamSeq perform similarly well, each
identifying six genes that showed evidence for gender specific gene expression in previous
studies, whereas the majority of genes identified by edgeR and DESeq Liberal have not
been indicated before and are most likely false positives. A random subset, i.e. ten male
and ten female samples, of the Cheung data was used to investigate the robustness of
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the findings from the full dataset. Results obtained with gamSeq proved to be the most
robust although five genes without prior evidence for gender specific gene expression were
identified. However, gamSeq’s increased false positive rate is modest when compared to
the breakdown in performance of edgeR and to a lesser extend DESeq Conservative.
Similar observations with regard to false positive findings could be made using the Mari-
oni and Gilad data where gamSeq performs well in both cases while DESeq Conservative
performs well for the larger dataset but does produce a significant number of false positive
findings when applied to the smaller dataset. DESeq Liberal and edgeR do both show the
same tendency towards false positive findings that was observed in the Cheung data.
Table 4.4. Genes called significant at a 10% FDR cutoff when testing for gender
differences.
Dataset Chromosome edgeR DESeq Lib. DESeq Cons. gamSeq
Chen
chr X 5 3 2 4
chr Y 10 17 16 15
autosomal 2 18 0 1
Cheung Full
chr X 2 10 0 1
chr Y 5 7 6 5
autosomal 22 231 0 0
Cheung SS20
chr X 12 8 1 0
chr Y 2 5 6 5
autosomal 240 182 31 5
Marioni
chr X 0 0 0 0
chr Y 0 0 0 0
autosomal 10 19 0 0
Gilad
chr X 1 1 0 0
chr Y 1 1 0 0
autosomal 57 39 37 0
4.3.3 Impact of zero-inflation on power and type I error
As indicated in the introduction, zero-inflation can play a significant role for a subset of
genes and it was of interest to determine how the statistical properties of the four methods
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change when zero-inflation is present. To that end, the simulation studies described
in Section 4.2.2 were used to assess power at a 10% FDR cutoff and size at a 0.001
significance level. Figures 4.7 and 4.8 as well as Supplementary Tables A.4 and A.5 show
size estimates for four levels of zero-inflation across 64 simulated datasets for scenario 2
and 4 based on dispersion estimates obtained from the Cheung dataset. Zero-inflation
seems to impact DESeq and edgeR differently. Both DESeq methods show inflated type
I error rates for increasing values of the zero-inflation parameter pi and decreasing sample
size while edgeR is highly conservative for even small levels of zero-inflation. gamSeq on
the other hand hovers around nominal size across all scenarios. The proposed method has
also the edge with regards to power when zero-inflation is present. Figures 4.9 and 4.10
as well as Supplementary Tables A.6 and A.7 show power estimates for aforementioned
simulations. At the same nominal level, gamSeq outperforms the other methods for sample
sizes of twelve or larger across all scenarios. The difference in performance becomes more
pronounced with larger values of the zero-inflation parameter.
4.3.4 Implementation
The method is implemented in the R package gamSeq available at
www.people.vcu.edu/∼mreimers. The package depends on the gamlss package version 4.1.
Convergence rates for the different approaches are shown in Table 4.5.
Table 4.5. Convergence rates for the Chen, Marioni, and Cheung datasets
Dataset
Method
edgeR DESeq Lib. DESeq Cons. gamSeq
Chen 95.5% 96.4% 96.3% 96.7%
Marioni 81.0% 100.0% 99.9% 93.5%
Cheung 89.9% 100.0% 99.9% 99.0%
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Figure 4.7. Size estimates for scenario 2 at 0.001 significance level. The red line
indicates nominal level.
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Figure 4.8. Size estimates for scenario 4 at 0.001 significance level. The red line
indicates nominal level.
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Figure 4.9. Power estimates for scenario 2 at 10% FDR cutoff.
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Figure 4.10. Power estimates for scenario 4 at 10% FDR cutoff.
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4.4 Conclusions and Discussion
RNA-Seq studies are a powerful tool to test hypotheses regarding differences in tran-
scription levels on a genome-wide basis. In contrast to microarray data that contains
continuous measures of light intensity emitted due to hybridization of cDNA fragments
to probes representing a gene as proxy for its transcription level, RNA-Seq experiments
measure a gene’s transcription abundance through counts of cDNA fragments mapping to
that gene. The discrete nature of RNA-Seq data led to new applications of existing sta-
tistical models for analyzing count data in a high-throughput fashion. After the Poisson
distribution was deemed as insufficient to explain biological variation in gene counts, the
negative binomial distribution with its additional overdispersion parameter θ has been the
distribution of choice to analyze RNA-Seq data. Early methods such as DESeq and edgeR
used the properties of the NB distribution and empirical or Bayes approaches to increase
power through sharing information across genes in studies with few biological replicates.
Through the framework of GLMs these methods have been extended to analyze more
complex experimental designs that include multiple potential confounders in addition to
the covariate of interest.
In this chapter, gamSeq, a method based on the NB distribution with a zero-inflation
component, was proposed to analyze complex RNA-Seq type studies and compared to
existing methods across a wide range of sample sizes and hypothetical distributions of
the dispersion parameter θ derived from real data since its true distribution is unknown.
Several statistical properties including type I error, power, and bias of parameter esti-
mates were investigated. Through simulation studies it was shown that the proposed
method is more robust than existing methods with regards to controlling type I error
across a number of different dispersion distributions. The existing methods edgeR and
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DESeq Liberal were shown have increased size at a 0.001 significance level for a number
of scenarios while gamSeq reliably controlled across all scenarios. A third method, DESeq
Conservative, was considered and shown to be a conservative alternative that maintained
size below the nominal level. The importance of controlling type I error was demonstrated
by testing for gender differences in one internal and three publicly available datasets. DE-
Seq Liberal and to a lesser extend edgeR identified a significant number of false positives
for a number of datasets while gamSeq reliably identified genes known to show gender
specific gene expression. DESeq Conservative performed similar to gamSeq for a num-
ber of datasets, but was shown to have the same tendency for false positives as DESeq
Liberal when multiple cells had only one biological replicate, e.g. in datasets with few
biological replicates per parameter fitted. The simulation studies also provided a reason-
able explanation why existing methods fail control type I error in certain scenarios by
showing that in general dispersion estimates obtained through information sharing across
genes slightly overestimate the true underlying dispersion, but for a subset of genes, these
methods significantly underestimate dispersion. Since the estimate of variance for a NB
distribution is linearly related to the estimate of the dispersion parameter θ, underesti-
mating the dispersion translates into an underestimate of variance that in turn can lead
to false positives. In contrast, the proposed method gamSeq generally underestimates
the true underlying dispersion slightly, but was shown to be less prone to significantly
underestimate dispersion resulting in maintaining type I error at nominal level.
While controlling type I error is a necessary and desirable property for any statistical
method used for inference, it should not be achieved through sacrificing statistical power,
i.e. the ability to detect true biological differences. The same simulation studies used
to investigate type I error were used to demonstrate that the proposed method achieves
similar or better power compared to edgeR and DESeq Liberal and is superior to DESeq
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Conservative for sample sizes of twelve or larger. A significant loss of power could be
observed for a sample size of nine when fitting three categorical covariates, which trans-
lates into three observations per parameter fitted. In any traditional statistical analysis
fitting a GLM this sample size would be considered insufficient to attain reasonable power
when fitting a single model, not to mention fitting 10,000-20,000 models. For these small
sample sizes methods that share information across genes seem to provide merit although
positive results should be examined critically as it was shown that false positives are still
a concern.
The gamSeq algorithm also addresses the phenomenon of zero-inflation, i.e. a higher
number of zeros than expected from a NB distribution with given mean and dispersion,
observed in more complex datasets. The gamSeq algorithm uses a screening procedure
to identify genes with potential zero-inflation and introduces an additional zero-inflation
parameter pi when needed. Empirical and statistical evidence was presented to illustrate
the problem and simulation studies were used to investigate its impact on power and type
I error. It was shown that gamSeq performs significantly better than existing methods
when zero-inflation is present and sample sizes are larger than or equal to twelve indi-
cating that the same sample size limitations as observed for data generated from a NB
distribution apply.
The gamSeq algorithm relies on the gamlss fitting algorithm, which was chosen due to its
robustness and potential to fit more complex models that can include random and non-
parametric effects. With the decreasing costs of RNA-Seq studies, longitudinal studies,
studies exploring gene expression from different tissues of the same individual, or studies
with technical replicates will become, or already are, feasible and will require explicit
modeling of the dependencies among observations. The flexibility of the gamlss algorithm
in principle allows implementation of such modeling approaches and extending the current
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R package to include such terms in RNA-Seq analyses will be considered in the future.
Recent studies have also uncovered that GC-content biases across samples may pose a
serious problem [27, 67]. It may well turn out that some of the variance observed in the
data is due to these biases. The gamlss algorithm allows explicit modeling of distribution
parameters such as the overdispersion parameter through additional terms. For example,
an adjustment for GC-content biases by modeling overdispersion as a function of gene
specific GC-content could be implemented.
First exploratory analyses using random effects and non-parametric terms indicate that
maintaining satisfactory convergence rates, computational efficiency, and desired statisti-
cal properties will be challenging. Issues that come with mixed models such as negative
estimates of variance components, slow convergence of fitting algorithms, and difficulties
in accurately estimating the variance-covariance matrix of parameter estimates multiply
when fitting 10,000-20,000 generalized mixed models at a time and innovative solutions
are needed.
In summary, insight into the behavior of existing methods to analyze RNA-Seq data
quantifying transcription levels is provided and their limitations are demonstrated. A
method is proposed that addresses the majority of limitations as well as the issue of
zero-inflation that affects a subset of genes. Furthermore, a brief outlook to future devel-
opments in the field is provided along with an outline of major challenges existing methods
are not able to address.
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Chapter 5
Alternative Usage of mRNA
polyadenylation sites
5.1 Introduction
Termination of transcription at the 3’ end of genes has long been suspected to play an
important role in regulation of gene expression [56, 69]. Lutz and Moreira [49] state that
alternative usage of polyadenylation sites can affect important molecular processes such as
RNA stability, translation, gene expression silencing, cell development and differentiation
or genomic maintenance. The authors categorize polyadenylation events into three types
shown in Figure 5.1. Biologically it is of interest whether the ratio of events of type
II and III varies significantly between different groups, e.g. different tissues or disease
groups. The high resolution of RNA-Seq enables researches to investigate differential
termination of gene transcription and detect novel 3’ untranslated regions (UTRs) or
polyadenylation sites. This chapter introduces statistical methods to test for differential
usage of polyadenylation sites using count data obtained through RNA-Seq experiments.
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Figure 5.1. Scenarios considered for differential 3’ UTR usage analysis [49].
Note that events of type II represent a differential use of polyadenylation sites while events
of type III represent differential use of 3’ UTRs. In the following differential usage of 3’
UTRs and differential usage of polyadenylation sites will be used interchangeably keeping
the difference in mind.
5.2 Materials and Methods
5.2.1 3’ UTR Database Used And Corresponding Read Counts
The AceView database curated by Danielle and Jean Thierry-Mieg [102] provides a com-
prehensive and non-redundant sequence representation of all public mRNA sequences
(mRNAs from GenBank [8] or RefSeq [76], and single pass cDNA sequences from dbEST
[13] and Trace [9]). These experimental cDNA sequences are first co-aligned on the genome
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then clustered into a minimal number of alternative transcript variants and grouped into
genes. AceView is arguably the richest transcript database currently available, contain-
ing more than 250,000 transcripts along with corresponding UTR regions. The UCSC
Genome Browser [82] incorporates AceView annotations and therefore was utilized to
create a database of 3’ UTRs matching scenarios II and III in Figure 5.1. Since differ-
ent datasets were aligned to different builds of the NCBI reference sequence, the following
steps were repeated for the NCBI36/hg18 assembly as well as the NCBI37/hg19 assembly:
1. extract genomic coordinates for all AceView transcripts and the corresponding
3’UTR regions as well as coding regions with respect to NCBI36/hg18 (AceView
build April 2007) and NCBI37/hg19 (AceView build February 2011)
2. For each gene, extract all combinations of 3’ UTR regions that correspond to type
II and III in Figure 5.1.
3. For each combination, remove regions that overlap coding regions, i.e. regions that
are used as protein coding regions in a different transcript. If the entire range of
either one of the 3’ UTR regions in a combination is used as a protein coding region,
then remove the combination from the putative 3’ UTR regions.
4. From the remaining combinations for each gene, choose the combination of 3’ UTR
regions that is supported by the most cDNA clones in the AceView database as the
3’ UTR region of interest.
Step 3 is necessary to ensure that sequenced reads that map to 3’ UTR regions are
representative of a UTR rather than a coding region of a transcript overlapping a specific
UTR. After step 4, the database contains two 3’ UTR regions for each gene and scenario.
10,184 genes had 3’ UTR combinations structured according to type II while 3,827 genes
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had 3’UTR combinations structured according to type III. Read counts for each 3’ UTR
region and sample were obtained by counting how many uniquely mappable reads with
at most one mismatch mapped to the corresponding genomic coordinates with a minimal
overlap of three base pairs to account for possible base call errors.
5.2.2 Testing for Differential 3’ UTR Usage Between Individual
Samples
Due to cost constraints of HTS, many early RNA-Seq studies lack biological replicates.
Often it is still of interest to make inferences about differential 3’ UTR usage between
individual mRNA samples extracted from two separate conditions or tissues. To illustrate
how to statistically analyze differential 3’ UTR usage using data from individual samples,
RNA-Seq data obtained by Illumia from their HiSeq 2000 platform [24] was used to extract
read counts for 15 different human tissue types (see Table A.8) sequenced with 75bp single
end reads for a total of 15 lanes with 50-70 million reads per lane. For each tissue, read
counts were obtained by using the algorithm outlined in Section 5.2.1. A multiplicative
model for ratios of Poisson rates between UTRs based on the GLM framework introduced
in Section 3.2.1 was then used to test for differential 3’ UTR usage:
log(n ∗ λ) = α + β1 ∗ tissue+ β2 ∗ region+ β12 ∗ region ∗ tissue (5.1)
Since this is a multiplicative model, testing for the interaction between region and tissue,
i.e. testing
H0 : β12 = 0 vs. Ha : β12 6= 0, (5.2)
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is equivalent to testing whether the ratios in read counts for the two UTR regions differ
significantly between tissues. A LRT test was used to test the interaction. Note that this
model assumes that observations from overlapping or independent 3’ UTR regions from
the same gene are statistically independent. Realistically this assumption is violated for
both types of polyadenylation events since two read counts are obtained from the same
sample, one for each region. This equates to a model with two repeated measures per
sample. Since there are only four degrees of freedom available when fitting the full model
described in Equation 5.1, additional terms such as a random effect that could account for
repeated measures designs could only be added with additional replicates. This concern
is given further consideration in the next section.
5.2.3 Testing for Differential 3’ UTR Usage Between Two Con-
ditions With Biological Replicates
In more complex study designs it is often of more interest to compare two groups, e.g.
disease patients against normal controls, with each group having multiple biological repli-
cates. The framework presented in Section 5.2.2 can easily be extended to this scenario.
The Chen dataset introduced in Section 3.2.4 was used to illustrate the proposed model.
Recall that the Chen dataset contained reads for 82 sequenced brain samples from normal
controls (n=26) and patients with bipolar disorder (n=25) or schizophrenia (n=31) and
included information on age, brain pH, and post mortem interval (PMI), which were used
during model fitting in addition to gender and diagnostic group. Since the some of the
samples were sequenced at very low coverage due to multiplexing, all samples with less
than one million uniquely mappable reads were excluded leaving 62 samples, 19 samples
from normal controls, 13 samples from patients with bipolar disorder, and 30 samples
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from patients with schizophrenia. It was of interest to test whether read count ratios are
significantly different between diagnostic groups.
A multiplicative model similar to that shown in Equation 5.1 was fit using the zero-
inflated model introduced in Chapter 4.
log(n ∗ λ) = α + β1 ∗ group+ β2 ∗ region+ β12 ∗ region ∗ group
+ β3 ∗ age+ β4 ∗ sex+ β5 ∗ pH + β6 ∗ PMI
(5.3)
To further account for the repeated measures design, the model described in Equation 5.3
was also fit with an additional random term γi ∼ N(0, σ2rI) where i=1,...,N and I is a 2×2
identity matrix, using the glmmADMB package. Again, since this is a multiplicative model,
testing for the interaction between region and group is equivalent to testing whether ratios
in read counts between two 3’ UTR regions differ significantly between diagnostic groups.
P-values based on Wald-type tests were used to test the interaction.
5.3 Results
5.4 Testing for Differential 3’ UTR Usage Between
Individual Samples
The method outlined in Section 5.2.2 was used to test for differential 3’ UTR usage
between tissues in the Bodymap dataset. The focus was the comparison of 3’ UTR usage
between brain and the remaining tissues since Sandberg et al. [88] suggested that mRNA
transcripts in brain tissue have longer 3’ UTRs. For polyadenylation events of type III,
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35%-50% of genes with detectable expression levels showed evidence for differential usage
at a 10% FDR cutoff when comparing brain tissue to the other 14 tissues. Among these
genes, 53%-65% used longer 3’ UTRs in brain. Similar observations could be made for
polyadenylation events of type II where 35%-62% of genes showed evidence for differential
usage at a 10% FDR cutoff with 53%-69% of those genes using longer 3’ UTRs in brain
tissue. Please refer to Supplementary Tables A.8 and A.9 for more details.
5.5 Testing for Differential 3’ UTR Usage Between
Two Conditions With Biological Replicates
Using models similar to the model described in Equation 5.3, the influence of diagnostic
group, brain pH, age, and PMI on differential usage of 3’ UTRs was investigated. Brain
pH was chosen as it has been shown to affect RNA integrity [94]. RNA degrades first
from the 3’ end [72] and therefore low RNA integrity could affect the number of fragments
in 3’ UTRs. PMI and age have not been found to be correlated with RNA integrity [41]
and are not expected to have an effect on apparent 3’ UTR usage. Diagnostic group was
the variable of interest as differences in 3’ UTR usage in patients with bipolar disorder or
schizophrenia when compared to normals would be an interesting biological phenomenon.
Figure 5.2 shows p-value plots for age, PMI, brain pH and diagnostic group after testing
for the interaction in model 5.3 without random effect term. No genes showed evidence for
an effect of age, PMI, or diagnostic group on 3’ UTR usage at a 10% FDR cutoff. However,
significant evidence for an effect of brain pH was found for 13 genes after multiple testing
correction. Similar results were found when a random effect was included in the model
(see p-value plots in Figure 5.3. Again, no genes showed evidence for differential 3’ UTR
usage depending on age, PMI, or diagnostic group while 26 genes, including all 13 genes
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found when omitting a random effect term, were found to show significant effect of brain
pH on 3’ UTR usage.
5.6 Conclusions and Discussion
In this chapter, a method based on the GLM framework was introduced to test for dif-
ferential usage of 3’ UTRs in two scenarios. The method was applied to two datasets for
which count data for UTR usage were extracted from reads aligned to the human reference
genome. The results obtained for the Bodymap dataset, i.e. a majority of genes show
evidence for differential 3’ UTR usage and transcripts in brain tissue have a slight pref-
erence towards longer UTRs, were consistent with observations made in previous studies
indicating that the proposed method gives sensible results.
Sensible results were also obtained when applied to the more complex Chen dataset. While
age and PMI do not seem to have an effect on differential 3’ UTR usage, a number of
genes showed evidence for an effect of brain pH. Interestingly, brain pH has been previ-
ously indicated to affect RNA integrity, which is often low due to RNA degradation at
the 3’ end of transcripts. Popova et al. [72] indicate that longer transcripts are more
affected by RNA degradation at the 3’ end. The mean length of transcripts associated
with genes listed in Table 5.1 is 3920bp while the mean length of all other transcripts in
RefSeq is 2970bp (t=1.79, df=47,p=0.0397 for one-sided test) supporting this conclusion.
While positive results could be obtained, the statistical power of the proposed method
is seriously limited in the Chen dataset by its lack of sequencing coverage. Seventy-five
percent of the shorter region of 3’ UTRs have mean counts of 30 or lower with 50% having
mean counts of 5 or lower. Future datasets with significant higher sequencing coverage
will allow a more detailed investigation of 3’ UTR usage using the proposed method.
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Age PMI
Brain pH Diagnostic Group
Figure 5.2. P-value plots for age, PMI, brain pH and diagnostic group
omitting a random effect term.
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Age PMI
Brain pH Diagnostic Group
Figure 5.3. P-value plots for age PMI, brain pH and diagnostic group
including a random effect term.
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Since by design of the proposed method observations are correlated, the merit of including
a random effect term in model 5.3 was evaluated. To that end, the glmmADMB was used
and the number of significant genes showing evidence for 3’ UTR usage influenced by
brain pH could be doubled. These results indicate that including a random effect should
be considered for study designs with repeated measures in space or time. However, first
exploratory analyses regarding power, type I error, and convergence rates show that the
glmmADMB package might not perform well for small sample sizes. Further research in
this direction, i.e. how to fit 10,000-20,000 generalized linear mixed models at a time
with satisfactory statistical properties and convergence rates along with computational
efficiency, is needed.
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Table 5.1. Genes with evidence for correlation between differential 3’ UTR usage and
brain pH
Gene Length of exonic regions (bp)
ANXA5 1599
ARF3 3537
BAD 1493
BPNT1 2461
DDX55 2622
FABP3 1097
GDAP1 4113
GSTO1 1310
GTPBP2 2979
HSPA5 3970
KLC1 3158
LMO4 5406
MGAT4A 10915
CLVS1 3492
NRN1 2056
PCLO 22498
PTPRS 7347
PUM1 5514
RAB5C 2031
RTN3 6691
SREBF1 5001
STX17 6908
TOLLIP 3660
TSGA13 1653
VAMP1 6044
ZCCHC9 1994
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Table A.1. Size estimates at significance level 0.001 across 64 simulated data sets
under various dispersion distribution scenarios and sample sizes
Method
Scenario
1 2 3 4
Marioni (N=18)
edgeR 0.00192 0.00127 0.00217 0.00275
DESeq Liberal 0.00201 0.00096 0.00691 0.00751
DESeq Conservative 0.00066 0.00049 0.00073 0.00084
gamSeq 0.00103 0.00098 0.00116 0.00110
Cheung (N=41)
edgeR 0.00129 0.00132 0.00192 0.00173
DESeq Liberal 0.00502 0.00140 0.00815 0.00856
DESeq Conservative 0.00057 0.00053 0.00050 0.00055
gamSeq 0.00100 0.00099 0.00119 0.00111
Cheung (N=18)
edgeR 0.00160 0.00141 0.00252 0.00281
DESeq Liberal 0.00344 0.00109 0.00751 0.01000
DESeq Conservative 0.00087 0.00051 0.00080 0.00096
gamSeq 0.00110 0.00106 0.00124 0.00114
Cheung(N=15)
edgeR 0.00177 0.00135 0.00237 0.00335
DESeq Liberal 0.00266 0.00087 0.00576 0.00857
DESeq Conservative 0.00090 0.00044 0.00091 0.00126
gamSeq 0.00110 0.00121 0.00122 0.00114
Cheung (N=12)
edgeR 0.00175 0.00136 0.00291 0.00381
DESeq Liberal 0.00213 0.00075 0.00528 0.00768
DESeq Conservative 0.00095 0.00040 0.00107 0.00166
gamSeq 0.00103 0.00105 0.00120 0.00105
Cheung (N=9)
edgeR 0.00156 0.00131 0.00310 0.00419
DESeq Liberal 0.00123 0.00067 0.00353 0.00496
DESeq Conservative 0.00085 0.00045 0.00179 0.00269
gamSeq 0.00083 0.00085 0.00149 0.00076
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Table A.2. Median (MAD) number of false positives at FDR cutoff of 10% across 64
simulated data sets under various dispersion distribution scenarios and sample sizes
Method
Scenario
1 2 3 4
Marioni (N=18)
edgeR 3 (3) 0 (0) 7 (3) 10 (5.9)
DESeq Liberal 7 (3.7) 1 (1.5) 102 (11.9) 109 (15.6)
DESeq Conservative 0 (0) 0 (0) 0 (0) 1 (1.5)
gamSeq 0 (0) 0 (0) 0 (0) 0 (0)
Cheung (N=41)
edgeR 0 (0) 0 (0) 2 (1.5) 1 (1.5)
DESeq Liberal 40 (8.2) 4 (3) 89 (13.3) 94 (14.1)
DESeq Conservative 0 (0) 0 (0) 0 (0) 0 (0)
gamSeq 0 (0) 0 (0) 0 (0) 0 (0)
Cheung (N=18)
edgeR 1 (1.5) 0 (0) 4 (3) 7 (5.9)
DESeq Liberal 16 (8.2) 2 (2.2) 74 (13.3) 116 (16.3)
DESeq Conservative 0 (0) 0 (0) 1 (1.5) 2 (1.5)
gamSeq 0 (0) 0 (0) 1 (0.7) 0 (0)
Cheung(N=15)
edgeR 1 (1.5) 0 (0) 5 (4.4) 9 (5.2)
DESeq Liberal 8 (4.4) 1 (1.5) 51 (11.1) 92 (13.3)
DESeq Conservative 0 (0) 0 (0) 1 (1.5) 2 (3)
gamSeq 0 (0) 1 (1.5) 1 (1.5) 1 (0.7)
Cheung (N=12)
edgeR 1 (1.5) 0 (0) 8 (4.4) 15 (5.9)
DESeq Liberal 5 (4.4) 1 (1.5) 41 (7.4) 79 (11.1)
DESeq Conservative 1 (0.7) 0 (0) 2 (1.5) 6 (3)
gamSeq 1 (1.5) 2 (1.5) 3 (3) 2 (1.5)
Cheung (N=9)
edgeR 1 (1.5) 1 (0) 10 (4.4) 18 (6.7)
DESeq Liberal 1 (1.5) 1 (1.5) 18 (7.4) 33 (8.2)
DESeq Conservative 1 (0) 0 (0) 7 (3) 11 (6.7)
gamSeq 1 (1.5) 2 (1.5) 7 (3) 3 (1.5)
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Table A.3. Power estimates at FDR cutoff of 10% across 64 simulated data sets under
various dispersion distribution scenarios and sample sizes
Method
Scenario
1 2 3 4
Marioni (N=18)
edgeR 0.544 0.485 0.493 0.508
DESeq Liberal 0.569 0.503 0.511 0.521
DESeq Conservative 0.545 0.453 0.460 0.472
gamSeq 0.543 0.462 0.499 0.538
Cheung (N=41)
edgeR 0.597 0.576 0.538 0.587
DESeq Liberal 0.619 0.597 0.554 0.606
DESeq Conservative 0.583 0.563 0.494 0.566
gamSeq 0.667 0.627 0.589 0.668
Cheung (N=18)
edgeR 0.518 0.518 0.464 0.531
DESeq Liberal 0.526 0.529 0.464 0.536
DESeq Conservative 0.477 0.483 0.402 0.488
gamSeq 0.547 0.516 0.450 0.588
Cheung(N=15)
edgeR 0.491 0.483 0.430 0.506
DESeq Liberal 0.486 0.475 0.418 0.497
DESeq Conservative 0.434 0.428 0.359 0.454
gamSeq 0.487 0.453 0.408 0.547
Cheung (N=12)
edgeR 0.468 0.464 0.395 0.480
DESeq Liberal 0.458 0.451 0.374 0.467
DESeq Conservative 0.400 0.398 0.309 0.422
gamSeq 0.415 0.390 0.315 0.479
Cheung (N=9)
edgeR 0.373 0.382 0.268 0.387
DESeq Liberal 0.346 0.355 0.228 0.352
DESeq Conservative 0.283 0.283 0.177 0.309
gamSeq 0.126 0.116 0.058 0.193
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Table A.4. Size estimates at significance level 0.001 across 64 simulated data sets in
scenario 2 with zero inflation
Method
pi
0.05 0.10 0.15 0.2
Cheung (N=41)
edgeR 0.00042 0.00029 0.00025 0.00022
DESeq Liberal 0.00142 0.00144 0.00156 0.00053
DESeq Conservative 0.00059 0.00076 0.00072 0.00012
gamSeq 0.00090 0.00093 0.00109 0.00113
Cheung (N=18)
edgeR 0.00027 0.00036 0.00032 NA
DESeq Liberal 0.00157 0.00232 0.00349 0.00485
DESeq Conservative 0.00096 0.00161 0.00240 0.00382
gamSeq 0.00124 0.00120 0.00134 0.00139
Cheung(N=15)
edgeR 0.00032 0.00033 NA NA
DESeq Liberal 0.00165 0.00267 0.00398 0.00585
DESeq Conservative 0.00124 0.00203 0.00317 0.00474
gamSeq 0.00132 0.00133 0.00157 0.00159
Cheung(N=12)
edgeR 0.00027 0.00052 NA NA
DESeq Liberal 0.00208 0.00414 0.00594 0.00970
DESeq Conservative 0.00161 0.00338 0.00490 0.00799
gamSeq 0.00106 0.00121 0.00137 0.00141
Cheung (N=9)
edgeR 0.00036 0.00047 NA NA
DESeq Liberal 0.00353 0.00709 0.01258 0.01655
DESeq Conservative 0.00302 0.00583 0.01043 0.01362
gamSeq 0.00062 0.00062 0.00062 0.00100
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Table A.5. Size estimates at significance level 0.001 across 64 simulated data sets in
scenario 4 with zero inflation
Method
pi
0.05 0.10 0.15 0.2
Cheung (N=41)
edgeR 0.00087 0.00066 0.00048 0.00065
DESeq Liberal 0.00793 0.0073 0.00615 0.00443
DESeq Conservative 0.00053 0.00058 0.00058 0.00043
gamSeq 0.00114 0.0011 0.00119 0.00119
Cheung (N=18)
edgeR 0.00131 0.00092 0.00144 0.00083
DESeq Liberal 0.00921 0.00897 0.009 0.00949
DESeq Conservative 0.0014 0.00158 0.00237 0.00282
gamSeq 0.00115 0.00116 0.00126 0.00145
Cheung(N=15)
edgeR 0.00152 0.00073 0.00069 NA
DESeq Liberal 0.00815 0.00772 0.00818 0.00878
DESeq Conservative 0.00163 0.00231 0.00301 0.00453
gamSeq 0.00143 0.00137 0.00163 0.0016
Cheung(N=12)
edgeR 0.00179 0.00096 NA NA
DESeq Liberal 0.00748 0.00808 0.00922 0.01133
DESeq Conservative 0.00219 0.00351 0.00475 0.00694
gamSeq 0.00101 0.00111 0.00132 0.00147
Cheung (N=9)
edgeR 0.00129 NA NA NA
DESeq Liberal 0.00619 0.00923 0.01312 0.01703
DESeq Conservative 0.00407 0.00683 0.01069 0.01474
gamSeq 0.00052 0.00053 0.00047 0.00065
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Table A.6. Power estimates at 10% FDR cutoff across 64 simulated data sets in
scenario 2 with zero inflation
Method
pi
0.05 0.10 0.15 0.2
Cheung (N=41)
edgeR 0.517 0.465 0.41 0.353
DESeq Liberal 0.581 0.56 0.518 0.478
DESeq Conservative 0.545 0.523 0.468 0.387
gamSeq 0.607 0.604 0.587 0.563
Cheung (N=18)
edgeR 0.402 0.304 0.225 0
DESeq Liberal 0.502 0.472 0.457 0.423
DESeq Conservative 0.448 0.409 0.383 0.339
gamSeq 0.493 0.484 0.468 0.438
Cheung(N=15)
edgeR 0.343 0.239 NA NA
DESeq Liberal 0.443 0.414 0.381 0.356
DESeq Conservative 0.382 0.351 0.307 0.278
gamSeq 0.418 0.399 0.383 0.398
Cheung(N=12)
edgeR 0.313 0.176 NA NA
DESeq Liberal 0.421 0.392 0.348 0.319
DESeq Conservative 0.36 0.317 0.27 0.24
gamSeq 0.366 0.328 0.3 0.299
Cheung (N=9)
edgeR 0.186 0.061 NA NA
DESeq Liberal 0.312 0.275 0.235 0.213
DESeq Conservative 0.243 0.206 0.174 0.154
gamSeq 0.131 0.062 0.022 0.011
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Table A.7. Power estimates at 10% FDR cutoff across 64 simulated data sets in
scenario 4 with zero inflation
Method
pi
0.05 0.10 0.15 0.2
Cheung (N=41)
edgeR 0.523 0.467 0.41 0.363
DESeq Liberal 0.592 0.577 0.545 0.469
DESeq Conservative 0.545 0.525 0.496 0.396
gamSeq 0.661 0.642 0.629 0.609
Cheung (N=18)
edgeR 0.408 0.316 0.215 0.132
DESeq Liberal 0.508 0.481 0.455 0.425
DESeq Conservative 0.451 0.419 0.387 0.35
gamSeq 0.574 0.581 0.547 0.547
Cheung(N=15)
edgeR 0.364 0.246 0.166 NA
DESeq Liberal 0.465 0.434 0.395 0.365
DESeq Conservative 0.412 0.381 0.336 0.294
gamSeq 0.518 0.496 0.483 0.463
Cheung(N=12)
edgeR 0.331 0.187 NA NA
DESeq Liberal 0.437 0.387 0.352 0.314
DESeq Conservative 0.379 0.323 0.288 0.243
gamSeq 0.451 0.403 0.397 0.367
Cheung (N=9)
edgeR 0.192 NA NA NA
DESeq Liberal 0.31 0.265 0.224 0.197
DESeq Conservative 0.258 0.218 0.176 0.151
gamSeq 0.153 0.133 0.07 0.041
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Table A.8. Percentage of genes showing evidence for differential 3’ UTR usage and
percentage of those genes with using longer 3’ UTRs when compared to brain tissue for
UTRs of type III
Tissue Differential Usage Length
Blood 57.68% 66.91%
Muscle 62.11% 64.44%
Breast 41.18% 58.46%
Kidney 47.90% 58.61%
Lymphnode 58.33% 57.42%
Colon 46.38% 61.76%
Prostate 53.51% 60.38%
Testes 46.16% 69.02%
Hear 39.86% 69.12%
Lung 54.71% 64.77%
Ovary 34.85% 53.86%
Thyroid 39.97% 62.11%
Adrenal 40.96% 52.66%
Adipose 41.90% 68.42%
Table A.9. Percentage of genes showing evidence for differential 3’ UTR usage and
percentage of those genes with using longer 3’ UTRs when compared to brain tissue for
UTRs of type II
Tissue Differential Usage Length
Blood 53.51% 55.89%
Muscle 50.59% 56.71%
Breast 48.70% 63.61%
Kidney 36.20% 59.83%
Lymphnode 47.69% 57.16%
Colon 36.89% 53.31%
Prostate 37.12% 64.13%
Testes 43.23% 60.85%
Hear 44.21% 54.67%
Lung 36.58% 58.96%
Ovary 41.86% 64.92%
Thyroid 43.13% 53.36%
Adrenal 48.99% 57.73%
Adipose 42.65% 61.45%
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Figure B.1. Schematic of Illumina Genome Analyzer 2 workflow[50].
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Figure B.2. Schematic of ABI SOLiD workflow [50].
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Appendix C
Supplementary Code
This appendix demonstrates how the different methods were used to analyze the Marioni
dataset described in Section 3.2.3. The count file is available from
http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE17274.
The other datasets and simulation studies were analyzed in similar fashion.
First, the necessary libraries are loaded and a function geneChr is defined that extracts
the chromosome a gene is located on given an gene identifier.
> library(multicore)
> library(DESeq)
> library(edgeR)
> library(gamSeq)
> geneChr <- function(ids,counts,prin=F){
+ require(org.Hs.eg.db)
+ cat("Number of genes with evidence for DGE:",length(ids),"\n")
+ if(length(ids)>0){
+ cat("Distribution of genes across chromosomes:")
+ print(table(unlist(lapply(rownames(counts)[ids],function(x)
+ tryCatch(get(get(x,org.Hs.egENSEMBL2EG),org.Hs.egCHR),
+ error=function(x) NA)))))
+ }
+ }
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The Marioni dataset is read in and pre-processed. The Marioni dataset contains one
technical replicate for each sample. Only one replicate was used in the analyses presented.
> marioniCounts <- read.table("/home/tguennel/ZIM/
+ GSE17274_ReadCountPerLane.txt",as.is=T,sep="\t",header=T)
> rownames(marioniCounts) <- marioniCounts[,1]
> marioniCounts <- marioniCounts[,-1]
> # order by species and gender
> marioniCounts <- marioniCounts[,order(sub("^.*\\.", "",
+ colnames(marioniCounts)))]
> # remove zero rows and replicates
> marioniCounts <- marioniCounts[-which(rowSums(
+ marioniCounts[,seq(2,36,by=2)])==0),-seq(1,36,by=2)]
> species <- rep(c("HS","PT","RM"),each=6)
> gender <- rep(rep(c("F","M"),each=3),3)
> # create data frame
> dataF2 <- data.frame(gender=gender,species=species)
Now gamSeq is run in parallel using eight CPUs and the chromosomes for genes called
significant are shown.
> nCPUs <- 8
> fitGamSeq <- gamSeq(counts=as.matrix(marioniCounts),
+ covariates="gender+species", data=dataF2, offSet=colSums(marioniCounts),
+ numCPUs=nCPUs)
Starting analysis
1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ...
12 ... 13 ... 14 ... 15 ... 16 ... 17 ...
Analysis completed
> geneChr(which(p.adjust(fitGamSeq$pValue$genderM,method="BH")<0.1),
+ counts=marioniCounts)
Number of genes with evidence for DGE: 0
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The same is repeated for edgeR and DESeq using code as suggested by the package’s
authors.
> design <- model.matrix(~gender + species ,data=dataF2)
> edgeRdata <- DGEList(counts=marioniCounts,
+ lib.size=colSums(marioniCounts), group=dataF2$gender)
> edgeRdata <- calcNormFactors(edgeRdata)
> edgeRdata <- estimateGLMCommonDisp(edgeRdata,design)
> edgeRdata <- estimateGLMTrendedDisp(edgeRdata,design)
> edgeRdata <- estimateGLMTagwiseDisp(edgeRdata,design)
> fitER <- glmFit(edgeRdata,design=design)
> lrtX1 <- glmLRT(edgeRdata,fitER,coef=c("genderM"))
> geneChr((1:nrow(marioniCounts))[-fitER$not.converged][which(p.adjust
+ (lrtX1$table$p.value[-fitER$not.converged],method="BH")<0.1)],
+ counts=marioniCounts)
Number of genes with evidence for DGE: 10
Distribution of genes across chromosomes:
1 10 11 12 14 15 19 2 20 6
1 1 1 1 1 1 1 1 1 1
First DESeq Conservative is run.
> dataF3 <- data.frame(condition=gender,species=species)
> cds <- newCountDataSet( marioniCounts, conditions=dataF3)
> cds <- estimateSizeFactors(cds)
> cds <- estimateDispersions(cds,method="pooled",sharingMode="max")
> fit1M <- fitNbinomGLMs(cds,count~condition+species,
+ glmControl=list(maxit=1000))
.................
> fit0M <- fitNbinomGLMs(cds,count~species,glmControl=list(maxit=1000))
.................
> pGenderDESPooled <- nbinomGLMTest(fit1M,fit0M)
> pGenderDESPooled[union(which(!fit0M$converged),
+ which(!fit1M$converged))] <- NA
> geneChr(which(p.adjust(pGenderDESPooled,method="BH")<0.1),
+ counts=marioniCounts)
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Number of genes with evidence for DGE: 0
Now the same for DESeq Liberal.
> # DESeq-Blind
>
> cds2 <- newCountDataSet( marioniCounts, conditions=dataF3)
> cds2 <- estimateSizeFactors( cds2 )
> cds2 <- estimateDispersions(cds2, method = "blind",
+ sharingMode="fit-only")
> fit1M2 <- fitNbinomGLMs(cds2,count~condition+species,
+ glmControl=list(maxit=1000))
.................
> fit0M2 <- fitNbinomGLMs( cds2, count ~ species,
+ glmControl=list(maxit=1000))
.................
> pGenderDESBlind<- nbinomGLMTest( fit1M2, fit0M2 )
> pGenderDESBlind[union(which(!fit1M2$converged),
+ which(!fit0M2$converged))] <- NA
> geneChr(which(p.adjust(pGenderDESBlind,method="BH")<0.1),
+ counts=marioniCounts)
Number of genes with evidence for DGE: 19
Distribution of genes across chromosomes:
1 10 11 12 13 14 15 17 19 2 20 4 6
2 1 1 2 1 1 1 1 2 2 1 1 2
The follwing R version and package versions were used for all analyses.
• R version 2.14.0 (2011-10-31), x86_64-unknown-linux-gnu
• Locale: LC_CTYPE=en_US.UTF-8, LC_NUMERIC=C, LC_TIME=en_US.UTF-8,
LC_COLLATE=en_US.UTF-8, LC_MONETARY=en_US.UTF-8,
LC_MESSAGES=en_US.UTF-8, LC_PAPER=C, LC_NAME=C, LC_ADDRESS=C,
LC_TELEPHONE=C, LC_MEASUREMENT=en_US.UTF-8, LC_IDENTIFICATION=C
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• Base packages: base, datasets, graphics, grDevices, methods, splines, stats, utils
• Other packages: akima 0.5-4, AnnotationDbi 1.16.0, Biobase 2.14.0, DBI 0.2-5,
DESeq 1.6.0, edgeR 2.4.0, gamlss 4.1-1, gamlss.data 4.0-5, gamlss.dist 4.1-0,
gamSeq 0.1.0, lattice 0.20-0, locfit 1.5-6, MASS 7.3-16, multicore 0.1-7,
nlme 3.1-102, org.Hs.eg.db 2.6.4, RSQLite 0.10.0
• Loaded via a namespace (and not attached): annotate 1.32.0, genefilter 1.36.0,
geneplotter 1.32.1, grid 2.14.0, IRanges 1.12.1, limma 3.10.0, RColorBrewer 1.0-5,
survival 2.36-10, tools 2.14.0, xtable 1.6-0
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Work in Progress
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Ph.D..
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data.
Publications in Refereed Journals
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• Comparing performance of multi-class classification systems with ROC manifolds:
When volume and correct classification fails, Schubert CA and Guennel T, Com-
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• Identifying genes progressively silenced in preneoplastic and neoplastic liver tissues,
Archer KJ, Zhao Z, Guennel T, Maluf DG, Fisher RA, and Mas VR, International
Journal of Computational Biology and Drug Design, Vol. 3, No. 1, 52-67, 2010.
• An application for assessing quality of RNA hybridized to Affymetrix GeneChips,
Archer KJ and Guennel T, Bioinformatics 22: 2699-2701, 2006.
Scientific Software
• logitT R package, A BioConductor R package implementing the Logit-t algorithm
introduced in ”A high performance test of differential gene expression for oligonu-
cleotide arrays” by William J Lemon, Sandya Liyanarachchi and Ming You for use
with Affymetrix data stored in an AffyBatch object in R. (2008).
• PixelAnalyzer, An application for assessing quality of RNA hybridized to Affymetrix
GeneChips with Kellie J. Archer (2006).
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Information”, National Institute for Health, Bethesda, MD, September 2, 2009.
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ics I/II/III.
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